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ABSTRACT 
A Life Course Approach to Potentially Modifiable Risk Factors for Poor Semen Quality 
Linda G. Kahn 
 
 Poor semen quality is an indicator of male infertility and is also associated with a variety of 
adverse health outcomes in men. It is therefore important from both clinical and public health 
perspectives to discover predictors of poor semen quality, especially those that are potentially modifiable. 
My dissertation research focuses on two of these potential risk factors: adiposity and stress. Unlike most 
studies to date, which have only considered the relationship between these exposures and semen quality 
cross-sectionally, my research takes a life course approach. I explore associations between birth weight, 
adiposity in both childhood and adulthood, and allostatic load—a construct representing the effect of 
cumulative stress on the body’s regulatory systems—and three commonly-used semen outcome 
parameters: sperm concentration, percent progressive motility, and percent normal morphology. The logic 
that underlies this approach is that while sperm are constantly being produced from sperm stem cells in 
the testes, which would argue in favor of cross-sectional studies, the sperm stem cells themselves and 
the Sertoli and Leydig cells that stimulate and nurture that metamorphosis are laid down in the fetal 
period and undergo important developmental and proliferative phases during early childhood and puberty 
that affect their number and functional health in adulthood. 
Using data from 193 participants in the Study of the Environment and Reproductive health follow-
up to the Child Health and Development Studies birth cohort, I was able to calculate birth weight for 
gestational age percentile (bw/ga) and six age-appropriate adiposity measures (at 4 months, 12 months, 
and 4 years, and in participants’ 20s, 30s, and at the time of semen collection), then test for their 
independent, critical period, and cumulative associations with the three semen outcomes as well as a 
combined outcome measure of subfertility based on World Health Organization reference levels. While 
bw/ga was positively associated with sperm concentration, subsequent childhood adiposity measures 
showed increasingly negative associations, and none of the adult measures were significantly associated 
with concentration. By contrast, only adult measures were associated with motility and morphology. This 
suggests that there may be critical periods in childhood when adiposity negatively affects sperm 
	
concentration by interfering with the development and proliferation of Sertoli and Leydig cells. 
Accumulation of oxidative stress in the testes due to overweight/obesity may explain the negative 
relationships between adult adiposity and sperm motility and morphology. 
To investigate allostatic load’s relationship to semen quality, I conducted a pilot study at Columbia 
University’s Center for Women’s Reproductive Care that enrolled 61 men who were having their initial 
diagnostic semen analysis and blood draw on the same day. Blood samples were analyzed for 7 
biomarkers associated with homeostatic regulation across several physiologic domains. I then created an 
allostatic load scale in which participants were assigned 1 point for being in the high-risk quartile for 
systolic blood pressure, diastolic blood pressure, body mass index, or any of the biomarkers. In 
regression analyses, allostatic load was not associated with either sperm concentration or morphology, 
but showed an unexpected positive association with motility. This association was entirely driven by the 
six participants who scored 0 on the allostatic load scale and who did not differ from the rest of the 
sample in any way that could plausibly be linked to reduced motility. I therefore concluded that this was a 
spurious finding. In further analysis of the allostatic load variable itself, I found that few of its individual 
components were correlated with the semen outcomes. This contrasts with other studies of allostatic load 
and adverse health outcomes, but these have generally been conducted in either elderly or stressed 
populations, neither of which described my cohort. Allostatic load may not be a reliable measure of stress 
in reproductive age populations and may not capture regulatory systems appropriate to reproductive 
health outcomes. 
My dissertation highlights the value and challenges of conducting semen quality research from a 
life course perspective. Future studies should consider collecting longitudinal data on adiposity and 
stress, as well as repeated semen samples beginning in adolescence in order to further our 
understanding of the natural progression of semen quality across the reproductive life span and provide 
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I have divers times examined the same matter from a healthy man…not 
from a sick man…nor spoiled by keeping…for a long time and not liquefied 
after the lapse of some time…but immediately after ejaculation before six 
beats of the pulse had intervened; and I have seen so great a number of 
living animalcules…in it, that sometimes more than a thousand were moving 
about in an amount of material the size of a grain of sand.(1) 
 
Antoni van Leeuwenhoek’s startling description of thousands of “animalcules” in a drop of human 
semen marked a watershed moment in the study of human reproduction. Contrary to the prevailing belief 
at the time, which was that the egg contained all of the necessary elements for new life, Leeuwenhoek 
hypothesized that sperm contributed essential biological material to and played an equal role in 
embryonic creation(2). More than 300 years later, while Leeuwenhoek’s hypothesis has been proven 
correct, much remains to be learned about factors that influence sperm formation, semen quality, and 
successful fertilization. In my dissertation research, I have set out to fill three gaps in our understanding of 
this much larger puzzle: 1) to systematically review the literature on body mass index (BMI) and all three 
main indicators of semen quality: sperm concentration, motility, and morphology, 2) to investigate the 
relationship of birth weight and of adiposity across the life course to semen quality, and 3) to explore the 
association between cumulative stress and semen quality. 
Semen quality is an important topic for public health research for two main reasons. First, as 
Leeuwenhoek surmised, sperm are required for the creation of new human (and nonhuman—he went on 
to observe semen in many other animals) life, and poor semen quality can impair a man’s biological 
ability to produce offspring. Second, semen can potentially provide a window into men’s health, as poor 
semen quality has been linked to various adverse health outcomes. It has been suggested that poor 
semen quality may be like a canary in a coal mine, as it is a biological indicator that may signal a man’s 
vulnerability to future health problems(3). 
 
Male infertility is a common and costly public health problem. 
It is generally—although not universally(4, 5)--held that poor semen quality, assessed by 
conventional measures that include concentration, motility, and morphology, is an indicator of male 
subfertility(6), also known as male-factor infertility. Male-factor infertility plays a role in approximately 50 
	
	2 
percent of couples who seek infertility treatment annually in the United States(7), thereby contributing to 
the increasing use of expensive assisted reproductive technologies (ART). In 2013 (the most recent data 
available), 1.6% of all infants born in the United States (66,691 live births) were conceived via ART 
(range: 0.2% in Puerto Rico to 4.8% in Massachusetts)(8).  
While ART has made it possible for infertile heterosexual couples—as well as single women and 
same-sex couples—to have genetically-related offspring, those offspring are at increased risk for adverse 
health outcomes compared to naturally-conceived children. Whether these adverse outcomes are 
associated with the treatment itself or the underlying subfertility that necessitated it is still unresolved. For 
example, while a 2015 meta-analysis of data from 50 cohort studies including 161,370 ART and 
2,280,241 spontaneously conceived singleton pregnancies found that ART infants are substantially more 
likely than their non-ART counterparts to be of low (<2500 g) or very low (<1500 g) birth weight and to be 
born preterm (<37 completed weeks of gestation) or very preterm (<32 weeks)(9), a recent study of 
272,551 singleton sibling pairs that included 1,813 pairs discordant on conception (ART vs. natural) 
concluded that differences in birth weight and preterm birth between ART and naturally-conceived infants 
could be explained by underlying maternal subfertility(10). Intracytoplasmic sperm injection, an additional 
procedure specifically indicated in cases of male-factor infertility, is associated with additional increased 
risk of congenital malformations, especially of the male urogenital system(11); transmission of genetic 
abnormalities related to male infertility, such as cystic fibrosis and Klinefelter syndrome(12); imprinting 
disorders(13); and autism(14). 
Low birth weight and preterm infants are at increased risk of adverse perinatal and child health 
outcomes, including developmental delays, with consequent costs to individuals, families, and society. In 
2005, the Committee on Understanding Premature Birth and Assuring Healthy Outcomes of the Institute 
of Medicine estimated the societal economic burden of preterm births—including medical care, early 
intervention, special education, and lost productivity--to be $26.2 billion(15), with the 4.6% of preterm and 
5.0% of very preterm births associated with ART(8) accounting for more than $1 billion. ART infants are 
far more likely to be multiples than naturally-conceived babies (41.1% vs. 3.5% (8)), exponentially 
increasing delivery expenses and exacerbating the risk of prematurity and low birth weight associated 
with ART. Studies that suggest that the increased risk of adverse perinatal outcomes associated with ART 
	
	3 
may derive from the underlying subfertility that indicated treatment rather than the treatment itself(16, 17) 
only underscore the importance of identifying and mitigating factors that compromise fertility. 
 
Poor semen quality may also indicate an underlying health problem. 
In 2001, building on decades of observational evidence of an association between poor semen 
quality and testicular cancer(18-20), as well as coincident declines in semen quality(21) and increases in 
testicular germ cell cancer in industrialized Western countries(22-24), Skakkebaek et al. coined the term 
“testicular dysgenesis syndrome” (TDS) to describe a constellation of urogenital symptoms including not 
only poor semen quality and testicular cancer, but hypospadias and cryptorchidism, as well(25). They and 
others have suggested that these symptoms might share a common etiology stemming from an 
environmental exposure (e.g., an endocrine disrupter) or secular trend (e.g., the rising prevalence of 
obesity)(25-29), which may be associated with additional adverse health outcomes. Recent research 
indicates that poor semen quality may also be linked to other cancers(30, 31), cardiovascular disease(32, 
33), diabetes (reviewed in (34)), and overall comorbidity, as measured by the Charleston Comorbidity 
Index(32, 35). Semen quality has been found to be inversely associated with overall mortality in fertility 
clinic samples across different time periods and geographical settings(32, 33, 36, 37). While results for 
individual semen parameters vary across studies and disease types, the overall pattern suggests that 
poor semen quality may be a bellwether of elevated disease risk in men. Identifying and understanding 
potentially modifiable predictors of poor semen quality would therefore be a worthy public health goal. 
 
Adiposity and stress may be risk factors for poor semen quality. 
 Studies that report associations between BMI and semen quality frequently make headlines in the 
popular press, but three published systematic reviews and meta-analyses have not been uniform in their 
findings(38-40). In Chapter 1, I conduct a qualitative systematic literature review of 56 English-language 
studies published prior to August, 2016, that include a statistical test of BMI and at least one of the three 
main semen quality measures: sperm concentration, motility, or morphology. Because papers in this area 
are notably heterogeneous in terms of study population (general vs. fertility clinic vs. proven fertile), 
participant age (young vs. mixed), sample size, and distribution of BMI within the study sample, I consider 
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whether results differ according to each of these criteria. I also map the sites of the various studies in 
order to ascertain whether study results are clustered by geographic region.   
The vast majority of studies that consider BMI and semen quality are cross-sectional, and many 
justify that approach by the fact that the process of spermatogenesis occurs in the 74 days prior to 
ejaculation(41). But there is reason to hypothesize that adiposity at earlier periods in the life course—as 
well as the intrauterine environment itself—may influence the proliferation and development of Sertoli and 
Leydig cells in the testes that are responsible for sperm production and maturation and thereby affect 
semen quality. In Chapter 2, I explore this hypothesis by linking longitudinal data from selected male 
offspring from the Child Health and Development Studies pregnancy cohort to cross-sectional data from 
the Study of the Environment and Reproduction follow-up that contains semen quality measures from 
samples collected in middle age. In addition to analyzing whether birth weight for gestational age or any 
of six adiposity measures spanning early childhood and adulthood has an independent effect on sperm 
concentration, motility, or morphology, I test two models central to life course epidemiology theory(42): 
critical period and accumulation of risk. In a secondary analysis, I also explore whether trajectories of 
adiposity within childhood and adulthood, as well as across the life span, influence semen quality. 
Numerous studies have analyzed the relationship between current stress and semen quality 
(summarized in Chapter 3), and while their measures of stress (and anxiety) have differed, they have all 
been recent or current and based on either psychosocial constructs or life events. Taking a life course 
approach once again, I hypothesize that cumulative stress might also be worth considering as a predictor 
of semen quality. In Chapter 3, I investigate the association between allostatic load—a scale based on 
biological measures that theoretically reflects the wear-and-tear of cumulative stress on the body’s major 
homeostatic systems(43)—and sperm concentration, motility, and morphology. In addition to using the full 
10-item allostatic load scale, I also assess correlations between its individual components and semen 
quality in order to determine whether they work in sync, as Seeman et al. found in their study of allostatic 
load and cardiovascular disease(44), and between its metabolic and non-metabolic subdomains and the 




In summary, my dissertation is designed to fill specific gaps in the male reproductive health 
literature. First, my systematic review attempts to make some sense of the mixed results of prior studies 
of BMI and semen quality by analyzing them according to various features of their sample populations, 
which earlier reviews have not done. Second, my study of the relationship of birth weight and adiposity to 
semen quality is the first to test whether adiposity at various critical periods in childhood and adulthood is 
related to semen quality in midlife and whether there is a cumulative effect over time, questions that have 
not been able to be asked or answered in semen studies up until now, as they have not had the 
advantage of a longitudinal data set based on a discrete birth cohort that includes data from middle age. 
Finally, my study of allostatic load advances our understanding of how the embodiment of stress over 
time affects the three different semen parameters, in contrast to prior stress and semen studies that have 
all been cross-sectional and used external measures of stress. 
The broader goal of my dissertation project is to further our understanding of some of the 
biological mechanisms underlying sperm production, including whether physiologic stress related to 
adiposity is particularly detrimental at various times in the life course and whether particular systems of 
the body—metabolic vs. immune, for example—have stronger or weaker relationships to different semen 
parameters. In terms of public health, a better understanding of predictors of poor semen quality may 
ultimately help us to reduce the apparent decline in semen quality seen in many parts of the world that 
contributes to an increasing reliance on ART. It also may help us to provide early intervention to mitigate 





CHAPTER 1. THE RELATIONSHIP BETWEEN ADULT BODY MASS INDEX AND SPERM 






Numerous studies have investigated the relationship between body mass index (BMI) and semen quality, 
but results have been inconclusive. 
Objectives 
The objective of this study is to systematically review the literature on BMI and the three main semen 
parameters used to diagnose male infertility: sperm concentration, motility, and morphology. 
Data sources 
PubMed and EMBASE were searched using a combination of keywords and medical subject heading 
terms relating to adiposity and semen quality, and Web of Science was used to cull additional papers that 
referenced the six most frequently cited articles. 
Study eligibility criteria and participants 
All observational epidemiologic studies published in English in peer-reviewed journals through August 2, 
2016, that reported a statistical test of the relationship between BMI and any of the three semen 
parameters were eligible for inclusion except for those conducted in the context of cancer research, 
urogenital disorders, or outcomes of assisted reproduction. Eligible study populations included those 
sampled from fertility clinics or andrology labs, from populations with proven fertility, from the general 
population, and from a combination of different sources. 
Study appraisal and synthesis methods 
Titles and abstracts were screened in two rounds. Articles deemed eligible were then reviewed in full by 
the lead author, who abstracted data from the 56 papers that met all inclusion criteria. Results were 
summarized by semen outcome measure; stratified by study size, source population, participant age, 
whether or not they controlled for key covariates, and their percentage of overweight or obese 




The preponderance of evidence does not support a linear association between BMI and any of the semen 
outcomes. However, evidence suggests a likely inverse U-shaped relationship between BMI and sperm 
concentration and potentially a threshold effect in which men in the highest BMI categories have reduced 
percent motility and normal morphology. 
Limitations 
Although 664 records were reviewed, there is a chance that some were missed or eliminated in error. 
Despite stratifying results by various criteria, there was still substantial heterogeneity among studies 
based on cohort composition and analysis techniques that precluded definitive conclusions. 
Conclusions and implications of key findings 
Under- and overweight men have lower sperm concentration than men of normal weight, and there may 
be a negative association between BMI and percent motility and normal morphology at the high end of 
the BMI distribution. Latitude—an indicator of climate and light--and the presence of environmental 






Ecological studies that depict a gradual decline in sperm concentration since the 1930s(21), while 
controversial when originally published, have been replicated in several Westernized countries(45, 46) 
but with regional variation(47), suggesting the possible involvement of environmental exposures on sperm 
production. While chemical toxicants associated with industrialization such as persistent organic 
pollutants (POPs) (reviewed in (48)), phthalates (reviewed in (49)), and those contained in air 
pollution(50) have been implicated in this decline, another potential contributor is body mass index (BMI), 
which has been increasing concurrently with observed decreases in sperm concentration and in similar 
geographic regions(51). 
Numerous observational studies have examined the relationship between BMI and semen quality, 
but findings have been conflicting. While inconsistent covariate control may account for some of the 
discrepancy in results (some studies do not adjust for any; others adjust for different sets of covariates), 
the major source of noncomparability between studies that could explain their contradictory conclusions is 
heterogeneity among the populations sampled. Some studies sampled men from the general population 
while others recruited from fertility clinics and still others included only men of proven fertility. Some 
studies included men of all ages while others exclusively sampled young men (generally students or 
military recruits). Furthermore, studies were conducted in various regions, among populations with 
different racial and ethnic compositions, and in environmental contexts that differed according to both 
natural and chemical exposures. Any of these factors (fertility status, age, race/ethnicity, environmental 
conditions and exposures) could potentially interact with BMI to influence semen quality, thereby 
explaining the lack of consistent results among studies. In addition, the degree to which any of these 
factors are associated with the BMI distribution in a given study sample may influence its results. For 
example, if BMI is not associated with sperm concentration among men in the normal BMI range, but 
negatively associated with sperm concentration among men who are overweight or obese, analyses 
performed in cohorts comprising only young men, who generally have a BMI distribution that includes 
fewer subjects with high BMI than cohorts comprising men of all ages, will be less likely to detect 
associations driven by subjects in the overweight or obese category. 
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Despite this heterogeneity, three summary analyses of the relationship between BMI and semen 
quality have been conducted in recent years. MacDonald et al. performed both a systematic review and 
analysis, published in 2010. Their qualitative review of 13 studies of BMI and semen parameters(38) 
reported mixed results. Among the 10 studies that considered the relationship between BMI and sperm 
concentration, one found a positive association, while the rest found negative or no associations. One of 
4 studies that analyzed the relationship between BMI and morphology found a higher percentage of 
abnormal morphology among obese men vs. non-obese men, but the others found no association. None 
of the 5 studies that reported on BMI and motility found an association. For their analysis, they included 
only 5 studies (4,853 men in total) that reported mean or median total sperm count or concentration by 
BMI category. Mean or median values for each BMI category were extracted and weighted by the number 
of subjects in the BMI group. Using linear models clustered by study in which BMI category was 
considered as an ordinal variable, they concluded that BMI category was not associated with mean or 
median sperm concentration, mean or median total sperm count, semen volume, or average sperm 
motility. Their analysis of mean sperm concentration combined data from 4 studies that differed 
substantially in source populations: 2 large multisite studies that recruited men from the general 
population, one from Europe and one from China; and 2 small studies that recruited men from fertility 
clinics in Hungary. Their analysis of median sperm concentration used data from only 2 studies, both 
large and drawn from the general population, although one recruited men of various ages while the other 
included only young military recruits. Analyses of mean and median total sperm count also used data 
from only 2 studies each; data from 3 studies were used in the volume and motility analyses. Although 
their data were organized by BMI category, they did not test for nonlinear relationships.  
An updated collaborative meta-analysis by Sermondade et al. published in 2013(39) combined 
data from 21 studies (13,077 men in total) to assess the relationship between BMI, modeled categorically 
with BMI ≥18.5 and ≤24.9 kg/m2 as the reference group, and categories of total sperm count 
(azoospermia, oligozoospermia, and normozoospermia—no, low, or normal sperm count). Using random 
effects models in which studies were weighted by statistical size, they found a J-shaped association, with 
underweight men more likely to have azoospermia or oligozoospermia (odds ratio (OR) = 1.46, 95% 
confidence interval (CI) [1.14, 1.88]) compared to normal weight men, and an increasing dose-response 
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relationship between BMI and azoospermia or oligozoospermia among overweight, obese, and morbidly 
obese men (OR = 1.06, 95% CI [0.95, 1.18], OR = 1.31, 95% CI [1.07, 1.61], and OR = 1.97, 95% CI 
[1.27, 3.07], respectively) compared to normal weight men. The same J-shaped relationship was found 
when comparing odds of low sperm concentration (<15 million sperm/mL) across BMI categories. Results 
were comparable when stratified by study population (general vs. fertility clinic). 
In a meta-analysis published in 2015(40), Campbell et al. combined data from 17 studies that 
examined BMI category and sperm concentration, 13 conducted among men recruited from fertility clinics 
and 4 among men from the general population. Using a random effects model, they found no differences 
in mean concentration among BMI categories when the two groups were analyzed together or separately. 
Among the 12 studies that looked at BMI category and progressive motility, they found a small but 
statistically significant decrease in percent progressive motility among obese men compared to men with 
normal BMI (weighted mean difference (WMD) = -3.72%, 95% CI [−7.11, -0.33]). When the 9 clinical 
studies and 3 general population studies were analyzed separately, results were in the same direction but 
not statistically significant. Campbell et al. also found that obese men had significantly reduced percent 
normal morphology compared to men with normal BMI among 5 studies conducted in fertility clinic 
populations that used WHO criteria for classifying morphologically abnormal sperm (WMD = -2.08%, 95% 
CI [-3.25, -0.92]), but the relationship was no longer significant when the 2 clinical studies that used an 
alternative method, Kruger’s strict criteria, were added to the analysis.  
The inconsistent conclusions presented in these three papers reflect important methodological 
differences. Each focused on different semen quality outcomes and had different data formatting 
requirements for inclusion, so that only two studies were included in all three analyses. While MacDonald 
et al. chose to test only the significance of their linear regression coefficients and found no association 
between BMI and sperm concentration, Sermondade et al. found evidence of a J-shaped relationship with 
low sperm concentration and Campbell et al. found evidence of a negative association between obesity 
and percent motility and normal morphology when they compared means across BMI levels. All three 
groups appropriately dealt with heterogeneity across studies by using weighted linear regression and 
clustering or using random effects models, but none of them adjusted for any covariates in their models. 
MacDonald et al. did not perform any subgroup analyses, and Sermondade et al. and Campbell et al. 
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stratified by source population, but did not consider other potential sources of noncomparability that might 
bias their results.  
 The objective of this qualitative review is to summarize findings in the published literature relating 
to the relationship between BMI and the three semen parameters commonly used to diagnose male 
infertility(52)--sperm concentration, motility, and morphology—and assess whether any variability in 
results may be traced to differences in the fertility status of the source population, participant ages, study 




We conducted a systematic review and qualitative analysis of the published literature in 
accordance with the relevant Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines(53) (see Supplemental Table 1.1 for PRISMA checklist). 
 
1.3.2 Search Strategy 
We initially searched PubMed and EMBASE using a combination of keywords and medical 
subject heading terms relating to birth weight, adiposity, and semen quality, e.g., “sperm count,” “sperm 
motility,” “spermatozoon density,” and “semen parameters” (Supplemental Table 1.2). We then searched 
Web of Science for additional references that cited the six most frequently referenced articles on BMI and 
semen quality(38, 39, 54-57). Finally, we included any remaining articles mentioned in the three meta-
analyses described above(38-40) and one critical review of the literature(56). After duplicates were 
removed, our search yielded 664 distinct records. 
 
1.3.3 Eligibility Criteria 
In order to be as inclusive as possible, our review included all original observational studies that 
provided a statistical test of the relationship between adult BMI and one or more of three specified semen 
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quality outcomes: sperm concentration, percent motile sperm, and percent normal/abnormal morphology. 
The test may have constituted the study’s primary analysis or may have been conducted as part of 
preliminary bivariate analyses in cases when the main aim of the paper was to assess a different 
relationship. Eligible study populations included those sampled from fertility clinics or andrology labs who 
were having semen evaluations as part of an infertility workup, those sampled from populations with 
proven fertility, those sampled from the general population or subgroups whose fertility status was 
unknown, and those sampled from a combination of sources. Non-human studies, review articles, 
commentaries, editorials, case reports, clinical trials, and studies focused on semen quality in the context 
of cancer treatment, urogenital disorders, or ART outcomes were excluded. All English-language studies 
meeting these criteria that were accepted for publication in a peer-reviewed journal and publicly available 
through August 2, 2016, were considered for this review.  
 
1.3.4 Screening and Study Selection 
The titles and abstracts of retrieved articles were first screened by the primary investigator (LGK) 
in EndNote X7 to weed out those that clearly met predefined exclusion criteria. The remaining references 
were uploaded to Covidence where their abstracts were screened independently by two investigators 
(LGK and Elizabeth Widen) to assess whether they met both inclusion and exclusion criteria 
(Supplemental Table 1.2). Any disagreement or uncertainty as to the eligibility of an article was resolved 
through discussion. The full texts of all retained articles were reviewed by LGK, who eliminated those that 
did not meet the specified exposure and outcome definitions. 
 
1.3.5 Data Collection 
Information was extracted from each study and entered into an Excel spreadsheet under the 
following headlines: first author, date, title, study design, location, sample size, age, BMI distribution, 
source population, inclusion/exclusion criteria, exposure measure, outcome measure(s), covariates, and 
results for each semen outcome. Study findings were described and categorized as “no association,” 
“negative association,” or “positive association” if they reported a statistically significant test for 
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correlation, linear trend, or differences between groups. They were categorized as “non-linear” if they 
reported a U- or inverse U-shaped association. We based our categorizations on adjusted results when 
both unadjusted and adjusted were reported. Additional information was noted regarding each study’s 
design and analysis, including whether or not the authors used measured or self-reported height and 
weight to calculate BMI, followed a WHO semen analysis protocol, appropriately handled outcomes that 
were not normally distributed, and adjusted or restricted for age and length of abstinence since last 
ejaculation. This last criterion, one of several included in a proposed checklist for acceptable studies 
based on human semen analyses(58) (others were difficult to assess retrospectively or did not apply to 
analyses that were performed under earlier WHO protocols), was designated the marker of a high-quality 
analysis. Studies that included only young men were considered to be restricted for age; studies that 
accepted only semen samples provided within approximately 2-7 days of sexual abstinence were 
considered to be restricted for abstinence. 
 
1.3.6 Synthesis of results 
Results for the relationship between BMI and each of the three semen parameters were analyzed 
separately. In addition to considering the findings of all of the included studies, we compared subgroups, 
stratified by study size, quality, source population, participant age, and percentage of overweight or obese 
participants (BMI ≥25 kg/m2). We also mapped the results of the studies to ascertain if the results 
followed a geographical pattern using BatchGeo (BatchGeo LLC, Albany, NY). When a study was 
conducted in multiple locations, the sites were mapped separately if the authors confirmed that the results 
were the same across locations(54, 59, 60); otherwise, results were represented by a single marker at the 
first location listed by the authors. 
 
1.4 RESULTS 
1.4.1 Study Selection 
Our initial search garnered 664 unique references, 491 of which were eliminated upon initial 
screening of titles and abstracts by LGK. Of the 173 abstracts reviewed by both LGK and EW, 77 were 
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considered eligible according to predetermined inclusion and exclusion criteria. LGK reviewed the full 
texts and eliminated an additional 21 papers that did not meet the specified exposure or outcome 
measures or duplicated another study’s cohort, yielding 56 articles for inclusion (Figure 1.1). 
 
1.4.2 Study characteristics 
Characteristics of the 56 studies included in our analysis are presented in Table 1.1. Fifty-five 
(98%) tested an association between BMI and sperm concentration, 50 (89%) tested an association 
between BMI and percent motile sperm, and 41 (73%) tested an association between BMI and percent 
normal/abnormal morphology. Thirty-three studies (59%) drew subjects from fertility clinics or andrology 
labs, 2 studies (4%) recruited participants with proven fertility (partners of pregnant women), 17 studies 
(30%) included men from the general population or from subsamples of unknown fertility status (e.g., 
occupational cohorts), and 4 studies (7%) drew from a combination of sources. Five studies (9%) were 
restricted to young men, generally military recruits or students, ranging in age from 18 to 23, while the 
rest included men of mixed ages, overall ranging from 16 to 75 years. Sample sizes ranged from 42 to 
10,197. Of the 47 studies (84%) that reported the distribution of participants’ BMI, 9 (19%) enrolled <30% 
overweight or obese men and 19 (40%) enrolled >60% overweight or obese men (the latter group 
included 4 studies that recruited based on overweight/obesity status). Twenty-nine (52%) studies did not 
control for any covariates. The analyses presented in the remaining 27 studies (48%) were considered 
high quality, as they included, at minimum, age and abstinence time among the variables controlled for 
through restriction or regression.  
Studies were conducted in 39 different countries and on every continent except Antarctica. All 
analyses were cross-sectional, although in three cases the analyses were based on data abstracted from 




1.4.3 Results of individual studies 
1.4.3.1 Concentration 
 Table 1.2a summarizes our findings regarding sperm concentration. Among the 55 studies that 
tested the relationship between BMI and sperm concentration, 33 found no statistically significant 
association, 20 found a negative association, 1 found a positive association, and 1 found an inverse U-
shaped association. Fertility status did not appear to be related to the type of association reported: 57.6% 
of studies that found no association were conducted in a fertility clinic/andrology lab compared to 65.0% 
of those that found a negative association, and 30.3% of studies that found no association drew from the 
general population compared 25.0% of those that found a negative association. The two studies 
conducted among men of proven fertility both reported no association. All but one of the studies 
conducted among young men reported no association. Studies that found no association were more likely 
to be large (>600 participants) than those that found a negative association (42.4% vs. 20.0%) and less 
likely to be small (<100 participants; 12.1% vs. 35.0%), suggesting that limited sample size did not 
necessarily preclude the finding of statistically significant associations among the studies analyzed. The 
prevalence of overweight or obesity in the study samples appeared to be related to the type of 
association found: 27.3% of those that found no association had >60% overweight/obese participants 
compared to 50.0% those that found a negative association, while 45.5% of those that found no 
association had 30-60% overweight/obese participants compared to 15.0% of those that found a negative 
association. The one study to find a positive association had <30% overweight/obese participants. Finally, 
a greater percentage of studies reporting no association controlled for both age and abstinence in their 
analyses compared with those that found a negative association (51.5% vs. 40.0%), as did the study that 
found a positive association. 
 Among studies that controlled for both age and abstinence (high-quality analyses) were 17 that 
found no association, 8 that found a negative association, as well as the single study that found a positive 
association. Once again, study results differed according to the prevalence of overweight or obesity in the 
study populations: 35.3% of those that found no association enrolled >60% overweight/obese participants 
compared to 62.5% of those that found a negative association, while 35.3% of studies that found no 
association enrolled 30-60% overweight/obese participants compared to 12.5% of studies that found a 
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negative association. More studies that found no association were large compared to those that found a 
negative association (52.9% vs. 37.5%). Both of the small studies found a negative association, likely due 
to the fact that both of the small studies enrolled high percentages of overweight or obese men (in fact, 
one recruited exclusively obese men(77)) rather than to any inherent difference in their methods. The 
single study that reported a positive association was large, included a mixed-age sample from the general 
population, and had a low percentage of overweight or obese participants.  
 One large study with high-quality analyses, conducted by Jensen et al., reported an inverse U-
shaped association between BMI and sperm concentration. Those who were underweight and overweight 
had lower mean sperm concentration compared to those who had normal BMI (badj = -28.1, 95% CI [-
47.9, -8.3] and badj = -21.6, 95% CI [-39.4, -4.0], respectively). Notably, this study exclusively enrolled 
young military recruits, and only 19% of the sample had BMI ≥25 kg/m2(57). Lu et al. also observed that 
sperm concentration in underweight and obese men was lower than in normal weight men, but the 
differences were not statistically significant. Although they did not report details of their BMI distribution, 
the mean BMI in their sample was 23.9 kg/m2, which is one of the lowest reported among studies that 
included mixed-age samples(112). In both cases, the high percentage of men at the low end of the BMI 
range may have made it possible ascertain a difference between underweight and normal weight men 
that would not have been detectable in a cohort of men with higher BMIs. 
 When the results of all of the concentration studies were mapped, no obvious pattern emerged 
(Supplemental Figure 1.1a). When only the sites of the studies with high-quality analyses were mapped, it 
appeared that while the majority reported no association between BMI and sperm concentration, 4 of the 
8 studies that reported a negative association were clustered in northwestern Europe, between Paris and 
Norway(57, 62, 65, 77, 79). Two others were located in Northeastern/Midwestern US and Canada 
(multisite, results not reported separately)(66) and in northwestern Russia(74) (Figure 1.2a).  
  
1.4.3.2 Motility 
 Table 1.2b summarizes results from the 50 studies that analyzed the relationship between BMI 
and percent sperm motility. Thirty-six found no statistically significant association, 12 found a negative 
association, 1 found a positive association, and one found a U-shaped association. As with concentration, 
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fertility status did not appear to be related to study results: 63.9% of studies that reported no association 
drew from fertility clinics/andrology labs compared to 58.3% of those that reported a negative association 
and 27.8% of those that reported no association drew from the general population compared to 25.0% of 
those that reported a negative association. Both studies that included men known to be fertile reported no 
association. All of the studies conducted among young men reported no association. The sample sizes of 
studies were similarly distributed between those that found no association and those that found a 
negative association. Among those that reported no association, 27.8% were conducted among samples 
with a high percentage of overweight/obese compared to 66.7% of studies that reported a negative 
association, but the situation was reversed for studies in which 30-60% of participants were 
overweight/obese: 41.7% of studies reporting no association vs. 16.7% of studies reporting a negative 
association. Nineteen (52.8%) of the studies that found no association, six (50.0%) of the studies that 
found a negative association, and the study that found a positive association controlled for both age and 
abstinence; therefore, their analyses were considered to be high quality. 
 Among the studies presenting high-quality analyses, a higher percentage of those reporting no 
association compared to a negative association recruited from the general population (47.4% vs. 16.7%) 
and a lower percentage drew from fertility clinics/andrology labs (42.1% vs. 66.7%). None of the studies 
that found a negative association enrolled <30% overweight/obese, while two-thirds of studies that found 
a negative association included >60% overweight/obese participants. The single study that reported a 
positive association was large, included men of mixed ages from the general population, and enrolled 30-
60% overweight/obese participants. 
In contrast to their non-statistically significant inverse U-shaped finding for sperm concentration, 
Lu et al. found a statistically significant U-shaped association between BMI and percent progressive 
motility in unadjusted analyses, with men in the highest and lowest BMI categories having higher motility 
compared to those in the normal BMI range(87). Bandel et al. also found that those in the obese category 
had higher motility compared to normal weight men; they may not have had enough men at the low end 
of the BMI range to detect a difference between underweight and normal weight men. 
 In both the map including all of the motility studies and the map including only the high-quality 
analyses, it was notable that all 4 sites that reported a positive association (representing Bandel et al.’s 
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multisite study in which the results were the same across sites(54, 59)) were located in Europe, and 
included the three northernmost locations of any studies: two in Greenland and one in upper Norway 
(Supplemental Figure 1.1b, Figure 1.2b). 
 
1.4.3.3 Morphology 
 Of the 41 studies that examined morphology, summarized in Table 1.2c, 31 found no statistically 
significant association between BMI and percent normal morphology, 8 found a negative association, and 
2 found a positive association. Studies that found no association were more likely than studies that found 
a negative association to be conducted among participants drawn from fertility clinics/andrology labs 
(67.7% vs. 25.0%) and less likely to be conducted among participants from the general population (19.4% 
vs. 50.0%). Both studies conducted among men of proven fertility and all four studies that included 
exclusively young men found no association. Among studies that found no association, 32.3% had large 
sample sizes compared to 50.0% of studies that found negative associations. Among studies that found 
no association, 32.3% included >60% overweight/obese participants compared to 62.5% of those that 
found a negative association. Fifteen (48.4%) of the studies that found no association, five (62.5%) of the 
studies that found a negative association, and both of the studies that found a positive association 
controlled for both age and abstinence. 
 Among the studies presenting high-quality analyses, a greater percentage of those that found no 
association recruited from fertility clinics/andrology labs compared to those that found a negative 
association (53.3% vs. 40.0%). A smaller percentage of those that found no association had a large 
sample size (46.7% vs. 60.0%) and >60% overweight/obese participants (33.3% vs. 60.0%) compared to 
those that found a negative association. The two studies that reported a positive association were 
conducted among men of mixed age; one was large and drew from the general population while the other 
was medium-sized and recruited subjects from fertility clinics. 
 When the results of all of the morphology studies were mapped, it became apparent that with the 
exception of a study conducted in New Zealand, which reported a positive association(88), all of the 
studies conducted in the southern hemisphere reported no association (Supplemental Figure 1.1c). When 
results of the high-quality analyses were mapped, all but one of the studies that found a negative 
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association were located in cold climates (Northeastern/Midwestern US and Canada (multisite, results not 
reported separately)(66), and northern Europe(62, 77, 102)) (Figure 1.2c). 
 
1.5 DISCUSSION 
1.5.1 Summary of evidence 
 Although the majority of studies reported no statistically significant association between BMI and 
sperm concentration, motility, or morphology, our review noted some trends that might suggest variations 
in these relationships based on characteristics of the study populations. In particular, sample BMI 
distribution and study location appear to be related to the direction of some of the associations.  
Not all studies reported the breakdown of their populations by BMI category, but among those 
that did, studies with high-quality analyses (controlling for both age and ejaculatory abstinence time) that 
enrolled high percentages (>60%) of overweight/obese participants were more likely to report negative 
associations between BMI and sperm concentration compared to those with 30-60% overweight/obese 
participants. These associations were driven by those in the overweight and/or obese categories, who in 
many cases had significantly lower mean sperm concentration compared to those in the normal 
category(64, 65, 74, 79, 106). By contrast, Qin et al., the only group to report a positive association, had a 
low percentage of overweight or obese participants (26.1%) and high percentage of normal or 
underweight participants (73.9%), with an overall mean sample BMI of 23.2 ± 2.9 kg/m2(95). Similarly, 
Jensen et al., whose sample was young and included few overweight or obese participants, noted that 
those with normal BMI had higher sperm concentration than those who were underweight. These findings 
are in keeping with Sermondade et al.’s meta-analysis that demonstrated a nonlinear association in which 
those in the normal BMI group (18.5 kg/m2 ≤BMI ≤24.9 kg/m2) had reduced odds of low sperm 
concentration compared to those in the underweight (BMI <18.5 kg/m2) and overweight/obese groups 
(≥25 kg/m2).  
Negative associations between BMI and motility found in high-quality analyses tended to be 
driven by those at the highest end of the BMI range. Andersen et al. reported that those who were 
morbidly obese had lower percent motility compared to those who were of normal weight(62), while 
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Bakos et al. found those who were morbidly obese had significantly lower percent motility compared to 
those who were obese, overweight, and normal weight(64). Among studies that reported a negative 
association between BMI and percent normal morphology, once again, the relationship was most 
apparent when contrasting those who were obese or morbidly obese to those who were normal 
weight(62, 84, 100, 102). As with concentration, Qin et al. found a positive association between BMI and 
percent normal morphology that was driven by differences between those who were underweight and 
those who were normal weight or overweight, which they were likely able to detect because of the 
relatively low BMI distribution in their sample(95). These findings suggest that the relationship between 
BMI and sperm concentration—and possibly motility and morphology--may not be linear and that there 
may be BMI thresholds above and below which negative effects may be seen. They also highlight the 
importance of insuring adequate sample size at the tail ends of the sample BMI distribution so that 
analyses are adequately powered to detect nonlinear associations. 
Much has been written about possible pathways linking obesity to reduced testosterone and, 
consequently, impaired sperm production(56, 113, 114). Obesity is associated with a constellation of 
hormonal dysregulation in men known as hyperestrogenic hypogonadotropic hypoandrogenemia: in the 
presence of excess adipose tissue, adrenal and testicular androgens are aromatized into estrogens, 
which suppress release of gonadotropins from the pituitary; with reduced hormonal stimulation, the 
Leydig cells in the testes produce less testosterone(113). In addition to aromatase, white adipose tissue 
produces leptin, which also downregulates testosterone production, and resistin, which is hypothesized to 
induce insulin resistance(114). High circulating insulin is associated with low total and free testosterone; 
there is some debate as to whether this relationship is mediated by sex hormone binding globulin. 
Overweight men are also at increased risk of sleep apnea, and both poor sleep quality and shortened 
sleep duration are risk factors for low testosterone(113). Increased adipose tissue in the genital area, 
especially in conjunction with sedentary behavior, can lead to higher scrotal temperature, which has been 
associated with reduced sperm concentration(56, 114). Motility may also be deleteriously affected by 
obesity, as insulin resistance is associated with increased levels of reactive oxygen species (free radicals 
that contain oxygen), which can damage sperm mitochondria(114). Reactive oxygen species also weaken 
the lipid structure of cell membranes, and to the degree to which the membranes of Sertoli cells, which 
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nurture developing spermatocytes, are involved in spermatid head-shaping and tail production, obesity 
may additionally affect sperm morphology(115). There is mounting evidence that POPs, which 
accumulate in fatty tissue, may impair semen quality(48, 116). Finally, recent research has identified a 
number of genes that are associated with both obesity and male infertility, raising the possibility that links 
between BMI and semen quality may result from a common genetic cause(117). 
Far less is known about the effects of underweight on semen quality. A case study that followed 
three male patients with acute anorexia nervosa through therapeutic weight gain provides provocative 
evidence that the hormonal profile of men with extremely low BMI may be similar to that of men with high 
BMI. Leptin, testosterone, and gonadotropin levels were all low at intake and increased with weight gain, 
and the change in leptin was positively correlated with changes in testosterone, luteinizing hormone, and 
follicle stimulating hormone (Pearson correlation coefficients (p-values): 0.55 (0.002), 0.46 (0.01), 0.81 
(0.0001), respectively)(118). 
The geographical distribution of the studies’ results, although not a source of statistical evidence, 
suggest two potential ways in which environmental factors may influence the relationship between obesity 
and semen quality. First, the clustering of all but two of the high-quality sites at which a negative 
association was found between BMI and sperm concentration, all of the high-quality sites at which a 
positive association was found between BMI and motility, and all but 1 of the high-quality sites where a 
negative association was found between BMI and morphology in northern Europe and northern North 
America may indicate potential moderation by factors associated with high latitude, such as climate and 
light. Second, 4 out of the 8 studies that found a negative association between BMI and sperm 
concentration were located in countries with high incidence rates of testicular cancer, including 2 studies 
conducted in Norway and Denmark, which have the highest age-standardized rates in the world (12.7 and 
12.5 per 100,000, respectively, in 2012)(119). Skakkebaek et al. have postulated that the coincident 
increase in testicular cancer, cryptorchidism, hypospadias, and poor semen quality in industrialized 
Western countries, a collection of urogenital conditions they refer to as testicular dysgenesis syndrome, 
may result from prenatal exposure to endocrine disrupters such as POPs(120). Several of these 
compounds have been associated with increased obesity in longitudinal studies of prenatal exposure to 
POPs and infant growth(121, 122) and early childhood adiposity(123), as well as adult dietary intake of 
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food containing polychlorinated biphenyls and subsequent development of obesity(124). A cross-sectional 
study using data from the National Health and Nutrition Examination Survey showed POPs to be more 
strongly associated with metabolically active trunk fat than leg fat(125). If confirmed, these findings would 
imply that in regions where POPs are prevalent, obesity and poor semen quality may not be causally 
related, but associated through a common environmental cause. 
 
1.5.2 Limitations 
Although 664 records were reviewed, there is a chance that some were missed or eliminated in error, 
which might lead to selection bias. Despite stratifying results by various criteria in order to reduce some of 
the heterogeneity among studies that plagues systematic reviews, there remained substantial differences 
among studies that precluded definitive conclusions. 
 
1.5.3 Strengths 
Because we included studies in which the relationship between BMI and semen outcome was not 
necessarily the main effect, we were able to include far more studies than the three prior published 
reviews. We also considered all three of the semen quality measures most commonly used to diagnose 
male infertility. While Campbell et al. stratified their results by fertility status, neither they nor the other two 
groups considered any of the other potential differences we identified among sample populations that 
might influence study findings. 
 
1.5.4 Conclusion 
The preponderance of evidence does not support a linear association between BMI and any of the semen 
outcomes: sperm concentration, motility or morphology. Results were similar when stratified by age, study 
population, study size, or quality. There is likely an inverse U-shaped relationship between BMI and 
sperm concentration, however, in which under- and overweight men have lower sperm concentration 
compared to normal weight men, and potentially a threshold effect in which men in the highest BMI 
categories have reduced percent motility and normal morphology. Future studies should explore potential 
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Table 1.2. Characteristics of studies of the relationship between BMI and semen quality. 
 
A. Sperm concentration 














Study population   
 
    
Fertility clinic/andrology lab 19 (57.6) 13 (65.0) 0 (0) 0 (0) 
General 10 (30.3) 5 (25.0) 1 (100) 1 (100) 
Proven fertile 2 (6.1) 0 (0) 0 (0) 0 (0) 
Other 2 (6.1) 2 (10.0) 0 (0) 0 (0) 
Age   
 
    
Mixed 29 (87.9) 20 (100) 1 (100) 0 (0) 
Young 4 (12.1) 0 (0) 0 (0) 1 (100) 
Study size   
 
    
Large (>600) 14 (42.4) 4 (20.0) 1 (100) 1 (100) 
Medium (100-600) 15 (45.4) 9 (45.0) 0 (0) 0 (0) 
Small (<100) 4 (12.1) 7 (35.0) 0 (0) 0 (0) 
BMI ≥25*         
Low (<30%) 4 (12.1) 2 (10.0) 1 (100) 1 (100) 
Medium (30-60%) 15 (45.5) 3 (15.0) 0 (0) 0 (0) 
High (>60%) 9 (27.3) 10 (50.0) 0 (0) 0 (0) 
Controls for age and abstinence (high quality)   
Yes 17 (51.5) 8 (40.0) 1 (100) 1 (100) 
No 16 (48.5) 12 (60.0) 0 (0) 0 (0) 
















    
Fertility clinic/andrology lab 8 (47.1) 4 (50.0) 0 (0) 0 (0) 
General 7 (41.2) 3 (37.5) 1 (100) 1 (100) 
Proven fertile 2 (11.8) 0 (0) 0 (0) 0 (0) 
Other 0 (0) 1 (12.5) 0 (0) 0 (0) 
Age 
  
    
Mixed 14 (82.4) 8 (100) 1 (100) 0 (0) 
Young 3 (17.6) 0 (0) 0 (0) 1 (100) 
Study size 
  
    
Large (>600) 9 (52.9) 3 (37.5) 1 (100) 1 (100) 
Medium (100-600) 8 (47.1) 3 (37.5) 0 (0) 0 (0) 
Small (<100) 0 (0) 2 (25.0) 0 (0) 0 (0) 
BMI ≥25*         
Low (<30%) 3 (17.6) 1 (12.5) 1 (100) 1 (100) 
Medium (30-60%) 6 (35.3) 1 (12.5) 0 (0) 0 (0) 
High (>60%) 6 (35.3) 5 (62.5) 0 (0) 0 (0) 
BMI: body mass index                                                         
All data reported as n (percent) 



















Study population   
 
    
Fertility clinic/andrology lab 23 (63.9) 7 (58.3) 0 (0) 1 (100) 
General 10 (27.8) 3 (25.0) 1 (100) 0 (0) 
Proven fertile 2 (5.6) 0 (0) 0 (0) 0 (0) 
Other 1 (2.8) 2 (16.7) 0 (0) 0 (0) 
Age   
 
    
Mixed 32 (88.9) 12 (100) 1 (100) 1 (100) 
Young 4 (11.1) 0 (0) 0 (0) 0 (0) 
Study size   
 
    
Large (>600) 14 (38.9) 4 (33.3) 1 (100) 1 (100) 
Medium (100-600) 16 (44.4) 6 (50.0) 0 (0) 0 (0) 
Small (<100) 6 (16.7) 2 (16.7) 0 (0) 0 (0) 
BMI ≥25*         
Low (<30%) 6 (16.7) 2 (16.7) 0 (0)   
Medium (30-60%) 15 (41.7) 2 (16.7) 1 (100)   
High (>60%) 10 (27.8) 8 (66.7) 0 (0)   
Controls for age and abstinence (high quality)   
Yes 19 (52.8) 6 (50.0) 1 (100) 0 (0) 
No 17 (47.2) 6 (50.0) 0 (0) 1 (100) 












 Study population 
  
  
 Fertility clinic/andrology lab 8 (42.1) 4 (66.7) 0 (0) 
 General 9 (47.4) 1 (16.7) 1 (100) 
 Proven fertile 2 (10.5) 0 (0) 0 (0) 




 Mixed 15 (78.9) 6 (100) 1 (100) 
 Young 4 (21.1) 0 (0) 0 (0) 
 Study size 
  
  
 Large (>600) 10 (52.6) 3 (50.0) 1 (100) 
 Medium (100-600) 8 (42.1) 2 (33.3) 0 (0) 
 Small (<100) 1 (5.3) 1 (16.7) 0 (0) 
 BMI ≥25*       
 Low (<30%) 6 (31.6) 0 (0) 0 (0) 
 Medium (30-60%) 4 (21.1) 2 (33.3) 1 (100) 
 High (>60%) 6 (31.6) 4 (66.7) 0 (0) 
 BMI: body mass index                                                          
All data reported as n (percent) 

















Study population   
 
  
Fertility clinic/andrology lab 21 (67.7) 2 (25.0) 1 (50.0) 
General 6 (19.4) 4 (50.0) 1 (50.0) 
Proven fertile 2 (6.4) 0 (0) 0 (0) 
Other 2 (6.4) 2 (25.0) 0 (0) 
Age   
 
  
Mixed 27 (87.1) 8 (100) 2 (100) 
Young 4 (12.2) 0 (0) 0 (0) 
Study size   
 
  
Large (>600) 10 (32.3) 4 (50.0) 1 (50.0) 
Medium (100-600) 16 (51.6) 3 (37.5) 1 (50.0) 
Small (<100) 5 (16.1) 1 (12.5) 0 (0) 
BMI ≥25*       
Low (<30%) 4 (12.2) 2 (25.0) 1 (50.0) 
Medium (30-60%) 12 (38.7) 1 (12.5) 0 (0) 
High (>60%) 10 (32.3) 5 (62.5) 1 (50.0) 
Controls for age and abstinence (high quality) 
Yes 15 (48.4) 5 (62.5) 2 (100) 
No 16 (51.6) 3 (37.5) 0 (0) 














Fertility clinic/andrology lab 8 (53.5) 2 (40.0) 1 (50.0) 
General 5 (33.3) 2 (40.0) 1 (50.0) 
Proven fertile 2 (13.3) 0 (0) 0 (0) 




Mixed 11 (73.3) 5 (100) 2 (100) 




Large (>600) 7 (46.7) 3 (60.0) 1 (50.0) 
Medium (100-600) 8 (53.3) 1 (20.0) 1 (50.0) 
Small (<100) 0 (0) 1 (20.0) 0 (0) 
BMI ≥25*       
Low (<30%) 4 (26.7) 1 (20.0) 1 (50.0) 
Medium (30-60%) 4 (26.7) 1 (20.0) 0 (0) 
High (>60%) 5 (33.3) 3 (60.0) 1 (50.0) 
BMI: body mass index                                                          
All data reported as n (percent) 
*percentages do not add up to 100 because not all studies reported BMI distribution  
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('birth weight'/exp OR ‘birth weight’ OR 'body weight'/exp OR 'body mass'/exp OR ‘body mass 
index’ OR ‘bmi’ OR 'obesity'/exp OR ‘obesity’ OR ‘overweight’) AND ('sperm'/exp OR 
'spermatozoon'/exp OR 'spermatozoon density'/exp OR 'spermatozoon motility'/exp OR 'sperm 
quality'/exp OR 'semen analysis'/exp OR 'spermatozoon count'/exp or ‘semen quality’ or ‘semen 






((((((((((((birth weight[MeSH Terms]) OR body weight[MeSH Terms]) OR body mass index[MeSH 
Terms]) OR adiposity[MeSH Terms]) OR overweight[MeSH Terms]) OR obesity[MeSH Terms]) 
OR body mass index[Text Word]) OR bmi[Text Word]) OR birth weight[Text Word]) OR 
overweight[Text Word]) OR obesity[Text Word]) AND ((((((((semen[MeSH Terms]) OR semen 
quality[MeSH Terms]) OR semen analysis[MeSH Terms]) OR spermatozoa[MeSH Terms]) OR 
sperm count[MeSH Terms]) OR sperm motility[MeSH Terms]) OR semen quality[Text Word]) OR 
semen parameters[Text Word])) AND (Humans[Mesh] AND English[lang]) 
 
 
Inclusion criteria: A statistical test of the relationship between BMI and one or more of three 
semen parameters: sperm concentration, motility, and morphology 
 
Exclusion criteria: Animal studies, non-empirical articles (e.g., reviews, commentaries/editorials, 
clinical guidelines), clinical trials, case reports, studies of female infertility and reproduction, and 
studies of semen quality in the context of research into ART procedures and outcomes, male 
contraceptives, childhood cancer treatment, genetic/chromosomal abnormalities, hormonal or 
genitourinary conditions (e.g., varicocele, prostate inflammation, vasectomy reversal, congenital 
























































































































































































CHAPTER 2. THE RELATIONSHIP OF BIRTH WEIGHT AND OF ADIPOSITY ACROSS THE LIFE COURSE 
TO SEMEN QUALITY IN MIDDLE AGE: RESULTS FROM THE STUDY OF THE ENVIRONMENT AND 
REPRODUCTION FOLLOW-UP TO THE CHILD HEALTH AND DEVELOPMENT STUDIES 
 
2.1 ABSTRACT 
Introduction: Adiposity has been identified as a potentially modifiable risk factor for poor semen quality, 
yet prior studies of body mass index (BMI) and semen quality have been inconclusive, with most finding 
no linear association between current BMI and any of the three primary semen quality measures: sperm 
concentration, percent motile sperm, and percent sperm with normal morphology. 
Objectives: Using longitudinal data from the Child Health and Development Studies birth cohort merged 
with cross-sectional data from the Study of the Environment and Reproduction follow-up, we 1) examined 
independent relationships of birth weight for gestational age and of adiposity measures throughout early 
childhood and adulthood with semen quality, 2) tested critical period and cumulative life course models, 
and 3) explored whether changes in adiposity within childhood or adulthood, or across the lifespan are 
associated with semen outcomes in middle age. 
Methods: One hundred ninety-three non-azoospermatic participants who provided semen samples were 
included in our analytic sample. In addition to birth weight for gestational age percentile, we created age-
specific adiposity measures for three time points in childhood and calculated BMI for three periods in 
adulthood, then tested whether each individually predicted sperm concentration, percent progressive 
motility, or percent normal morphology in multivariate regression models. We also ran a series of nested 
models to test critical period effects, as well as models that used cumulative adiposity scores and 
trajectory variables as predictors. 
Results: We found a statistically significant positive association between birth weight for gestational age 
percentile and sperm concentration and null or negative associations between childhood adiposity 
measures and sperm concentration. Adiposity in adulthood, but not childhood, was negatively associated 




their 20s and a corresponding cumulative effect as they aged. Although not statistically significant, those 
who were overweight and obese in adulthood had increased odds of low percent normal morphology, with 
stronger associations for those who were overweight or obese in their 20s.  
Conclusion: Our findings of different effects of birth weight, childhood and adult adiposity measures on 
sperm concentration, motility, and morphology suggest various biological mechanisms by which these 
aspects of semen quality may be determined. Additional life course studies of adiposity and semen 
quality are warranted to confirm our results and expand them to include the important developmental 







Adiposity has been identified as a potentially modifiable risk factor for poor semen quality. 
Numerous studies of body mass index (BMI), a convenient—albeit crude--measure of adiposity, and 
various semen parameters have been conducted among adult men in diverse study populations around 
the world. With a single exception(126), all of them have been cross-sectional, allowing only for inference 
of the effect of current adiposity on sperm production. While these analyses may capture the effect of BMI 
on the 74-day process of spermatogenesis (from the mitotic division of the spermatogonia (stem cells of 
the male germinal cell line) through their daughter spermatocytes’ proliferation, migration, meiotic 
division, maturation, and differentiation into spermatozoa(41)), this represents only the culmination of a 
developmental trajectory that begins during fetal life and continues through puberty, adolescence, and 
into adulthood. There remains a wide gap in our understanding of how birth weight, as well as adiposity in 
infancy, childhood, young adulthood, and middle age may individually and cumulatively influence the 
biological mechanisms that determine different aspects of semen quality.  
The results of prior studies of BMI and semen quality have been inconclusive, with most finding 
no linear association between BMI and the three common semen quality measures: sperm concentration 
(millions/mL), percent motile sperm, and percent sperm with normal morphology (reviewed in (38-40)). 
There is some indication that there may be a nonlinear relationship between BMI and low sperm 
concentration, as a meta-analysis of 21 studies by Sermondade et al. found that underweight and 
overweight/obese men were at higher risk of low sperm count and concentration compared to men in the 
normal BMI range(39). A more recent meta-analysis by Campbell et al. found no relationship between 
BMI and sperm concentration, but suggests that any negative relationship between BMI and motility or 
morphology may be driven by men in the obese category(40). The overall inconsistency of these studies’ 
results likely stems from differences among their study samples in terms of racial/ethnic composition, 
environmental exposures, age (most included men of mixed ages, ranging from adolescence through old 
age, while a few focused exclusively on young men), sample BMI distribution, and fertility status (most 
recruited from fertility clinics, yielding a preponderance of subfertile men, while some recruited only fertile 




Fetal growth, for which birth weight for gestational age is commonly used as a proxy(127), 
provides a convenient, if imprecise, marker of conditions of the intrauterine environment that may exert a 
lasting influence on male reproductive potential. We found three published studies that examined the 
relationship between birth weight and semen quality. As a follow-up study of 347 men whose mothers 
were part of the Danish Healthy Habits for Two pregnancy cohort, Ramlau-Hansen et al. found no 
association between birth weight and semen quality at age 18-21 years(126). Olsen et al. reported 
reduced sperm concentration among men who were born between 3,000 and 3,999 g compared to those 
with lower or higher birth weights(128). Auger et al. found higher birth weight to be associated with an 
increase in abnormally shaped sperm(129).  
Additionally, there may be critical periods in childhood when adiposity may indelibly affect later-
life semen quality, possibly through alterations in pubertal timing and development. While numerous 
studies have documented an association between increased BMI in childhood and early onset of puberty 
in girls, research on boys has been sparse. Nevertheless, a few studies in varied populations have 
suggested an inverse relationship between childhood BMI and age at puberty in boys(130-135). Both 
early (0-12 months) and middle (2-8 years) childhood have been identified as potentially critical periods 
during which increased adiposity may affect male pubertal development(134, 135). While the biological 
mechanisms underlying these observed associations are not clear, it is theoretically possible that 
whatever hormonal pathways implicated in the timing of male puberty that may be disrupted by early 
childhood adiposity may also affect the maturation and proliferation of Sertoli and/or Leydig cells in the 
testes, thereby influencing semen quality in adulthood. In the one study we found that explored childhood 
adiposity and adult semen quality, Ramlau-Hansen et al. found no association between prepubertal BMI 
(age 5-8 years) and semen quality in young adulthood(126). It is also possible that the risk of poor semen 
quality accumulates with exposure to increased adiposity over the life course. 
The current study, conducted among participants in the Study of the Environment and 
Reproduction (SER) follow-up to the Child Health and Development Studies (CHDS) birth cohort, 
provided a unique opportunity to explore the relationship of birth weight and of adiposity across the life 
course to semen quality in middle age. Drawing on the methodological framework outlined by Elwer et 




Kuh in their seminal paper on life course epidemiology(42): critical period, in which an exposure at a 
particular point in biological development results in a permanent change in physiologic function that has 
lifelong effects, and accumulation of risk, in which the effect of an exposure increases according to the 
number of times the individual was exposed. In a secondary analysis, we also explored how changes in 
adiposity across childhood, adulthood, and the entire lifespan might affect semen quality in middle age. 
 
2.3 METHODS 
2.3.1 Study population 
The current analysis includes 193 middle-age men (mean age 43) whose mothers participated in 
the CHDS during pregnancy. The CHDS is a birth cohort that enrolled 98% of eligible pregnant women 
who were members of the Kaiser Foundation Health Plan in and around Oakland, California, between 
1959 and 1966. Women were recruited early to mid-pregnancy, at which time they provided a blood 
sample and underwent an extensive face-to-face interview that collected demographic, lifestyle, and 
background medical information about both them and their partners, as well as the women’s reproductive 
history and details of their current pregnancy. Follow-up data included additional prenatal blood samples, 
cord blood samples, questionnaires, and child growth and medical information, which were collected at 
regular intervals through age five. A subset of children was followed through puberty and adolescence.  
SER was one of a series of follow-up studies of CHDS child participants designed to investigate 
the impact of prenatal exposures and childhood growth and development on health in middle age. Men 
were recruited between December, 2005 and April, 2008 (mean age 43 years) with the aim of examining 
the effect of prenatal exposure to environmental chemical exposures on reproductive health, specifically 
time-to-pregnancy and semen quality. Men were eligible to participate if they had data on birth length and 
weight, at least one same-day height and weight measure between age 6 months and 5.5 years, maternal 
prenatal interview data, and an adequate volume of sera obtained from the mother in mid-pregnancy to 
measure maternal thyroid hormone and in the immediate postpartum period to assess the presence of 
environmental chemicals. They also needed to live within 100 miles of the Kaiser Oakland Clinic, as the 




congenital abnormalities. Attempts were made to contact 1,202 of the 3,531 ostensibly eligible 
participants from the recruitment pool. Of the 654 (54%) who were successfully reached, 568 met 
eligibility criteria, and 338 (60%) of that group consented to participate and provided interviews. Of those, 
196 (58%) additionally provided at least one semen sample (Figure 2.1)(137). SER participants who 
provided semen samples were comparable to the underlying non-preterm CHDS cohort in terms of 
gestational age and birth weight, but were less likely to be white. They were also less likely to be white 
and had lower gestational age compared to SER participants who did not provide semen samples 
(Supplemental Table 2.1). The current analyses exclude 3 SER participants who were azoospermatic 
(had no sperm cells in their semen). 
 
2.3.2 Study protocol 
 Upon recruitment, participants traveled to the Kaiser Oakland Clinic, where they underwent a 
one-hour in-person interview; were weighed, measured, and had blood pressure taken; and provided 
semen and blood samples. Topics covered in the interview included demographic information, health and 
medical history, reproductive health history, psychosocial stressors, lifestyle characteristics, and 
deleterious exposures. Blood samples were drawn following semen collection. Participants returned to 
the clinic approximately 2 weeks later to provide a second semen sample. Details of the study protocol 
have been published previously(137). 
 
2.3.3 Exposure measures 
2.3.3.1 Birth weight for gestational age 
We created sex-specific birth weight for gestational age percentiles (bw/ga) for participants using 
continuous curves derived from United States Natality datasets containing information on male singleton 
infants born to United States resident mothers in 1999-2000(138). Although these curves were created 
more than three decades after the last of the CHDS children were born, they are the first continuous 
curves available based on the entire US population; prior curves only provided data for specific 




populations(139, 140). Even if the bw/ga curve did shift in the intervening years, the rank order of the 
participants’ percentiles would remain the same.  
 
2.3.3.2 Adiposity measures 
Because measures of adiposity are not standard across the life course, we created several 
different variables appropriate to the critical periods hypothesized to be potentially relevant to semen 
quality. For the first two critical periods, at approximately 4 and 12 months of age, we calculated sex-
specific weight-for-age percentiles (wt/age) and sex-specific weight-for-height percentiles (wt/ht) using a 
SAS program provided by the Centers for Disease Control and Prevention (CDC) that draws on data from 
the 2000 CDC weight-for age and height-for-age growth charts for birth through 36 months(143). 
Although the first CDC growth charts became available in 1977, the 0-36 month curves were based on 
data from the longitudinal growth study of the Fels Research Institute in Yellow Springs, Ohio, which 
included mainly formula-fed white middle-class infants. The 2000 charts are based on data from the 
National Health and Nutrition Examination Survey (NHANES) I (1971-74), NHANES II (1976-1980), 
NHANES III (1988-94), and national birth certificate data from United States Vital Statistics that better 
reflect the racial/ethnic diversity of the CHDS cohort(144). For the third critical period, at approximately 4 
years of age, we used the CDC SAS program to calculate sex-specific BMI-for-age percentiles (ssBMI) 
based on 2000 CDC BMI-for-age growth charts. These charts reflect data from the three NHANES waves 
mentioned above as well as two earlier surveys, the National Health Examination Survey (NHES) II 
(1963-5) and NHES III (1966-70)(144). Categorical adiposity variables were created from the continuous 
variables using CDC cut points for child under/normal weight (<85th percentile), overweight (85th to <90th 
percentile), and obesity (≥95th percentile). 
Continuous BMI measures were calculated for three time periods in adulthood. Measured weight 
and height at the time of semen collection yielded current BMI. BMI in participants’ 20s and 30s was 
calculated from recalled weight, under the assumption that height is stable between early adulthood and 
middle age. Categorical adult BMI measures were created using World Health Organization (WHO) cut 
points for under/normal weight (<25 kg/m2), overweight (25 to <30 kg/m2), obese (30 to <35 kg/m2), and 




Cumulative overweight and cumulative obesity scores were created by allocating 1 point for every 
time period in which a subject was classified as either overweight/obese (≥85th percentile for child 
measures, ≥25 kg/m2 for adult measures) or simply obese (≥95th percentile for child measures, ≥30 kg/m2 
for adult measures). In addition to a 0-6 point scale that covered all 6 ages at which adiposity was 
measured, we created separate 0-3 point scales for cumulative child and adult overweight/obesity and 
obesity. Finally, we generated nominal categorical variables that represented trajectories of adiposity from 
4 months to 4 years of age and from participants’ 20s to their age at the time of the study, as well as two 
four-category lifetime trajectory variables representing ever/never overweight/obese and ever/never 
obese at any point in childhood vs. adulthood (Supplemental Table 2.2). 
 
2.3.4 Outcome measures 
 Participants were invited to provide two semen samples approximately two weeks apart, each 
after 2-5 days of ejaculatory abstinence. Only complete samples were analyzed; incomplete samples 
were discarded and men were asked to return at a later date. Semen analysis was performed according 
to a standard protocol: volume, sperm concentration, and percent motile sperm were assessed at the 
Kaiser Clinic within one hour and seminal smears were prepared and sent to the Andrology Laboratory at 
the University of California, Davis, where they were stained in order to determine percent normal 
morphology, which was classified according to strict criteria(145). Details of the semen analysis(137) and 
quality controls used throughout the procedure(146) have been described previously. Because the 
intraclass correlation coefficients for the three semen quality measures among men who provided two 
samples indicated good reliability between measures (ICCconc = 0.70, ICCmot = 0.65, ICCmorph = 0.80)(137), 
the mean value of each parameter was used when two were available and single values were used when 
only one was available.  
Semen parameters were modeled both as continuous variables and dichotomously using 2010 
WHO reference values for subfertility: sperm concentration <15 million/mL, percent progressive motility 
<32%, percent normal morphology (strict criteria) <4%(147). These values were updated based on 
samples from more than 1953 men in 8 countries who had known time to pregnancy ≤12 months(147), 




methodology behind the 2010 WHO reference values(149) and debate as to whether cutoff values for 
what is considered “normal” (the 5th centile of the reference ranges) are warranted when there is no 
evidence of a biological threshold effect(5). Nevertheless, these reference values are frequently cited in 
the literature and clinical practice as indicators of male subfertility. We additionally created a 3-level 
combined outcome measure for subfertility that categorized participants according to the number of 
parameters they had below the 2010 WHO reference values (0, 1, 2-3 parameters).  
 
2.3.5 Covariates 
Information on behavioral, sociodemographic, medical, and psychosocial risk factors for adiposity 
at different life stages and poor semen quality was assessed via questionnaire administered by trained 
interviewers. Prenatal variables were available, but were hypothesized to be linked to the outcomes 
primarily through their contribution to the adiposity exposures; we therefore chose not to include them in 
the analyses in order not to incur bias from overadjustment(150). Covariates that were identified as 
potential confounders and predictors of the outcomes based on a review of the literature and causal 
diagrams (Supplemental Figure 2.1) included: participants’ abstinence time (continuous, minutes), current 
age (continuous, years), race (white, black, other), education (high school, some college, bachelor’s 
degree, graduate level), annual income (<$50,000, $50-100,000, $100-150,000, >$150,000), smoking 
status (current vs. not current), alcohol consumption (continuous, average g/week during past 12 
months), caffeine consumption (continuous, average mg/week during past three months), exercise 
(continuous, average minutes/week during past 3 months), ever diagnosed with a sexually transmitted 
infection (Y/N), current hormone use (Y/N), and current employment status (employed/unemployed). 
Current stress and depression variables were also considered, as prior analyses in this data set found 
perceived stress, stressful life events, and unemployment to be associated with our semen 
outcomes(151). Available stress measures included the validated abbreviated 10-item Perceived Stress 
Scale (PSS)(152); a shortened form of the Life Events Inventory (LEI)(153), including the top 10 stressors 
of men from an occupational sample(154); the 16-item Job Content Questionnaire (JCQ)(155); and the 
20-item Center for Epidemiologic Studies Depression scale (CES-D)(156). PSS and CES-D were 




the sample median job demand score and below the sample median job control score on the JCQ were 
categorized as high strain; the rest were categorized as low strain. A three-level variable was created in 
which participants were categorized as unemployed, employed with low job strain, or employed with high 
job strain. 
 
2.3.6 Statistical analyses 
Univariate analyses were performed to describe the study sample and to compare it to both the 
source population of male CHDS participants and to SER participants who did not provide semen 
samples. We also examined histograms of the three semen parameters. In bivariate analyses, analysis of 
variance was used to compare means of continuous exposure and outcome variables (adiposity 
measures and the three semen parameters) according to levels of categorical covariates. Nonparametric 
Spearman correlations were used to assess associations between continuous variables. Chi-square tests 
were used to detect bivariate associations between categorical covariates. The relationships of adiposity 
in participants’ 20s, 30s, and at the time of the SER study to their semen quality were explored through 
data visualization techniques including scatterplots with loess smoothing curves and bar graphs showing 
the frequencies of each of the three dichotomous variables representing poor semen quality according to 
the WHO reference levels by BMI category.  
In regression analyses, we decided a priori to include participants’ race, current age, and 
abstinence time in all final models. To determine which additional covariates warranted inclusion in the 
final models, separate simple linear regression models were run to examine the association between 
bw/ga and each adiposity measure and the three outcome variables. Hypothesized confounders and 
predictors of the outcomes that changed the estimated regression coefficient of the predictor in the simple 
model by at least 50% of the standard error or were associated with the outcome with a p-value <0.10 
were included in the relevant covariate-adjusted models. Bw/ga, reflecting the cumulative effect of the 
prenatal environment on fetal growth, was considered as a primary exposure, but was also included as a 
covariate in all adiposity models as a proxy measure of the intrauterine environment. When the wt/ht 
variable was used to capture adiposity at 4 and 12 months, models were additionally adjusted for the 




 To test whether bw/ga and each of the adiposity measures was independently associated with 
each of the three semen outcomes, we ran a series of three models: 1) including only the main effect, 2) 
including the main effect, current age, race, and abstinence time, and 3) including the main effect, current 
age, race, abstinence time, and the additional covariates relevant to each parameter (bw/ga was 
additionally included in all childhood and adult adiposity models). Using linear regression for continuous 
outcomes and logistic regression for binary outcomes, this series was run with 1) continuous predictors 
and outcomes, 2) continuous predictors and dichotomous outcomes (based on WHO reference values), 
3) categorical predictors (based on cut points for overweight and obesity) and continuous outcomes, and 
4) categorical predictors and dichotomous outcomes. The same strategy was applied to the multinomial 
logistic models for the 3-level poor semen quality outcome variable based on the WHO reference levels to 
assess its association with either continuous or categorical predictors. In this case, dichotomous predictor 
variables were used (overweight/obese vs. normal and obese vs. normal/overweight) because the models 
failed to converge when the three-level categorical predictors were used. 
To test whether any of the adiposity measures exerted a critical period effect, a series of covariate 
unadjusted and adjusted nested linear regression models was run for each semen outcome. First, each of 
the three outcome variables was regressed on 4-month wt/age controlling for bw/ga, with and without 
covariates. Subsequent continuous critical period measures were added sequentially, culminating with 
current BMI. The exercise was repeated using 4- and 12-month wt/ht measures. Because the three 
continuous adult BMI measures were highly correlated and the estimated regression coefficients could be 
in opposite directions yielding ambiguous interpretations(157), in alternative analyses the series was run 
using variables that represented the differences in percentiles or BMI scores between adjacent time 
periods. 
The cumulative effect of adiposity was assessed by regressing the continuous semen outcomes 
on 1) the cumulative overweight/obese variable that included all 6 time points, 2) the cumulative 
overweight/obese variable that included the 3 childhood time points, and 3) the cumulative 
overweight/obese variable that included the 3 adult time points. We repeated this series using the three 





Finally, to test whether participants’ adiposity trajectory between 4 months and 4 years of age, 
between 20s and middle age, and between childhood and adulthood were related to semen quality, we 
regressed both continuous and dichotomous semen outcome measures on the nominal categorical 
childhood, adulthood, and lifespan trajectory variables with and without covariate adjustment. All analyses 
were performed in SAS 9.3 (SAS Institute, Cary, NC). 
 
2.4 RESULTS 
2.4.1 Descriptive analyses 
The 193 SER participants included in these analyses had a mean sperm concentration of 73.6 
million sperm/mL (range: 2.1-429.9 million/mL), mean percent progressive motility of 40.0% (range: 0-
76.5%), mean percent normal morphology of 7.6% (range: 0-20.0%), and mean current BMI of 28.8 kg/m2 
(range: 19.4-44.3 kg/m2). Participants did not differ significantly on demographic or behavioral 
characteristics according to their BMI category (Table 2.1). 9.8% of the sample was below the WHO 
reference level for sperm concentration (<15 million/mL), 32.6% was below the reference level for percent 
progressive motility (<32%), and 22.4% was below the reference level for percent normal morphology 
(<4%). 58.6% of the sample met none of the WHO criteria for poor semen quality, while 6.3% met all 
three (Supplemental Figure 2.2). Whereas motility and morphology were approximately normally 
distributed, sperm concentration was found to be right-skewed and was square-root transformed 
(Supplemental Figure 2.3). 
In bivariate analyses of potential covariates and semen parameters, African-American men had 
significantly lower percent progressive motility (32.3% vs. 41.3% and 43.3%) and normal morphology 
(6.6% vs. 7.3% and 9.5%) compared to white men and men of other racial backgrounds. Men who earned 
≤$50,000 per year had significantly lower percent progressive motility compared to the three higher 
income groups (35.5% vs. 41.6%, 45.0%, 41.3%, respectively). Similarly, men in the lowest education 
group (≤high school) tended to have lower percent progressive motility compared to the three higher 
education groups (34.2% vs. 41.3%, 39.4%, 42.3%, respectively), although this difference did not reach 




in this sample (p-value < 0.0001). Current smokers had significantly lower percent progressive motility 
(30.8% vs. 42.0%) compared to nonsmokers. Compared to employed men, unemployed men had 
significantly lower percent progressive motility (29.2% vs. 41.7%) and percent normal morphology (5.9% 
vs. 7.9%). Those who had experienced 2 or more adverse life events in the preceding 12 months also 
had significantly lower percent progressive motility and normal morphology compared to those who 
experienced fewer than 2. Age was significantly negatively correlated with all three semen outcomes, 
while perceived stress was negatively correlated with motility and morphology and depression was 
negatively correlated with motility. Increased abstinence time was significantly positively correlated with 
increased sperm concentration (Supplemental Table 2.3). 
The three semen parameters were all positively correlated with one another (range of 
coefficients: 0.37-0.52) (Supplemental Table 2.4). The three childhood adiposity measures were also 
positively correlated (range of coefficients: 0.35-0.67), as were the three adult adiposity measures (range 
of coefficients: 0.69-0.84). The only childhood adiposity measure to be associated with adult BMI was 4-
year-old ssBMI, which was significantly positively correlated with all of the adult measures (range of 
coefficients: 0.19-0.23) (Supplemental Table 2.5). 
 
2.4.2 Independent associations 
2.4.2.1 Concentration 
Bw/ga was positively associated with sperm concentration. For every percentile increase in 
bw/ga, square-root sperm concentration increased by 0.02x103 sperm/mL in covariate-adjusted analyses 
(95% confidence interval (CI) [0.00, 0.04]). Continuous childhood adiposity measures were not associated 
with sperm concentration, but categorical measures tended to be increasingly negative as time since birth 
elapsed. In particular, overweight at 4 years was significantly negatively associated with sperm 
concentration (badj = -1.70; 95% CI [-3.19, -0.21]). In logistic models, neither bw/ga nor any of the 
adiposity measures was associated with low sperm concentration based on the WHO reference level 





In contrast to the results for concentration, neither bw/ga nor early childhood adiposity measures 
was significantly associated with percent progressive motility. Participants who were obese in their 20s or 
30s tended to have lower percent progressive motility compared to men with BMI <25 kg/m2 in linear 
models (badj = -8.08; 95% CI [-17.13, 0.97], p-value = 0.08 and badj = -5.98; 95% CI [-12.46, 0.49], p-value 
= 0.07,respectively). Using the dichotomous outcome variable based on the WHO reference level for low 
percent progressive motility, we found that participants with higher BMI in their 20s and 30s had 
increased odds of low percent progressive motility in covariate-adjusted analyses (ORadj = 1.12, 95%CI 
[0.996, 1.25], p-value = 0.06 and ORadj = 1.09, 95% CI [0.998, 1.19], p-value = 0.06, respectively). 
Participants who were overweight in their 20s had 2.58 times the covariate-adjusted odds of low motility 
compared to those with BMI <25 kg/m2 (95% CI [1.10, 6.01]) and participants who were obese in their 30s 
had 3.18 times the covariate-adjusted odds compared to those with BMI <25 kg/m2 (95% CI [1.05, 9.66]) 
(Table 2.2b).  
2.4.2.3 Morphology 
None of the childhood or adulthood adiposity measures was significantly associated with percent 
normal morphology in covariate-adjusted linear models. Using the WHO-based dichotomous morphology 
outcome variable and logistic regression, we found that obesity at the time of semen collection was 
positively associated with low percent normal morphology (ORadj = 1.91; 95% CI [0.70, 5.27], p-value = 
0.07) (Table 2.2c).  
Results of the analyses of independent associations were similar when wt/ht measures were 
used instead of wt/age at 4 and 12 months, adjusting for participants’ age in days at those examinations. 
Loess smoothing curves of semen parameters by adult BMI reflected the findings of our 
regression analyses. In particular, they made visible the decline in sperm motility associated with 
overweight in participants’ 20s and obesity in their 30s. It was also apparent that there was no association 
between current BMI and motility (Supplemental Figure 2.4). In bar graphs showing the percent of 
participants below each semen parameter’s WHO reference value by BMI category, increasing BMI 




points. The relationship attained statistical significance for BMI in participants’ 20s (two-sided exact 
Cochran-Armitage trend test p-value = 0.02) (Supplemental Figure 2.5). 
Subfertility, defined as being below one or more of the WHO reference values, was related to 
adiposity in early adulthood, but not childhood or at the time of the study. Participants with BMI ≥25 kg/m2 
in their 20s had 3.52 times the covariate-adjusted odds of meeting 2-3 WHO subfertility criteria compared 
to participants who with BMI <25 kg/m2 (95% CI [1.42, 8.75]), and participants with BMI ≥30 kg/m2 at the 
time of semen collection had 2.42 times the covariate-adjusted odds of meeting 2-3 WHO subfertility 
criteria compared to participants who with BMI <30 kg/m2 (95% CI [1.04, 5.69]). For each 1-unit increase 
in BMI in their 30s, participants had on average a 11% increased covariate-adjusted odds of meeting 2-3 
subfertility criteria (95% CI [1%, 21%]) (Supplemental Table 2.6).  
 
2.4.3 Critical period models 
A critical period effect was identified if adiposity at a particular time point was associated with a 
semen outcome and maintained that association despite the addition of subsequent adiposity measures 
to the model(136). None of the child or adult adiposity measures demonstrated a statistically significant 
critical period effect on any of the semen outcomes (Tables 2.3a-c). The relationship between wt/ht at 12 
months and sperm concentration approached statistical significance and remained constant despite the 
addition of subsequent adiposity measures (badj = 0.03, 95 % CI [-0.00, 0.05]) (Table 2.3a). Results were 
comparable when we used categorical adult BMI measures and difference measures, and when we 
restricted analyses to only those who had adiposity measures at all six time points. 
 
2.4.4 Cumulative models 
The results of our analysis of a cumulative effect on semen quality paralleled our findings 
regarding independent associations. We found no association with sperm concentration when all 6 time 
points were represented in the cumulative overweight/obese and obesity predictor variables. When we 
modeled separate 0-3 point scales representing cumulative adiposity in childhood and adulthood, we 




obesity with sperm concentration using the childhood scales and no associations using the adulthood 
scales (Table 2.4a). By contrast, we found no associations between the total and childhood scales and 
progressive motility, but found a significant negative association using the adult cumulative obesity scale 
(badj = -2.60; 95% CI [-5.09, -0.12]) and a corresponding positive association between the adult 
cumulative overweight/obesity scale and low percent progressive motility (ORadj = 1.33; 95% CI [0.96, 
1.86], p-value = 0.09) (Table 2.4b). Both adult cumulative overweight/obesity and obesity scales were 
positively associated with low percent normal morphology (ORadj = 1.34; 95% CI [0.95, 1.89], p-value = 
0.096 and ORadj = 1.48; 95% CI [0.97, 2.26], p-value = 0.07, respectively) (Table 2.4c). When we 
restricted the adult analyses to only the participants with childhood measures, the associations were 
attenuated but in the same direction. 
 
2.4.5 Trajectory analyses 
In secondary analyses, we examined trajectories of adiposity over the course of childhood 
(between 4 months and 4 years) and adulthood (between 20s and age at semen collection), as well as 
over the entire lifespan. We did not find any associations with sperm concentration or percent progressive 
motility (Tables 2.5a-b). Compared to those who were never obese, those who were normal or overweight 
in childhood and obese in adulthood had increased percent normal morphology (badj = 3.52, 95% CI [1.68, 
5.36] (Table 2.5c). 
 
2.5 DISCUSSION 
 In keeping with the majority of published studies, we found no association between current BMI 
and sperm concentration. Our findings of a positive association between bw/ga and sperm concentration 
and increasingly negative associations between childhood adiposity measures and sperm concentration 
suggest that prenatal and early childhood periods may be important developmental windows for testicular 
Sertoli and Leydig cells, which control spermatogenesis. Sertoli cells, which are the first cells to 
differentiate in the fetal gonad, play an essential role in fetal and neonatal testicular development, 




masculinization of the fetus. In puberty, their role shifts to supporting the differentiation, meiosis, and 
transformation of spermatocytes into spermatozoa, under the hormonal regulation of testosterone 
produced by nearby Leydig cells. Sertoli cells proliferate during both of these periods; following puberty, 
they reach functional maturity and no longer multiply(158). Because each Sertoli cell can only support a 
fixed number of spermatocytes at a time(159, 160), prenatal conditions that affect Sertoli cell proliferation 
will affect sperm concentration later in life. A study of pregnant ewes fed high and low metabolizable 
energy diets found those fed the high-energy diets gave birth to heavier lambs and to lambs with 
significantly higher number of Sertoli cells per testis(161), suggesting that overall fetal growth and Sertoli 
cell proliferation may respond to common exposures in the intrauterine environment.  
Whereas Sertoli cells have two developmental phases, Leydig cells pass through three phases of 
maturation, from fetal to neonatal to adult Leydig cells, reflected in peaks of testosterone production at 
14-18 gestational weeks, 2-3 months of age, and from puberty onward. Postnatally, as Sertoli cells are 
entering a nonproliferative quiescent phase, Leydig cells are entering their second stage of development. 
After this second peak, a portion of neonatal Leydig cells regresses into immature Leydig cells, which 
eventually give rise to adult Leydig cells in puberty(162). Environmental circumstances that interfere with 
or promote successful regression may eventually influence the number of adult Leydig cells and 
consequently affect testosterone production in adulthood. Although our finding of a trend toward a critical 
period effect of adiposity at 12 months on sperm concentration should be interpreted with caution, as the 
models were unstable due to the collinearity of the childhood measures, they are in line with this 
proposed biological mechanism. 
In contrast to sperm concentration, which was solely influenced by prenatal and early childhood 
adiposity in our study, progressive motility was associated with adult adiposity measures, and most 
strongly with young adult measures. Obesity is associated with systemic buildup of excessive reactive 
oxygen species (ROS) (163)—unstable oxygen-containing molecules generated as a byproduct of cellular 
respiration--which can adversely affect sperm motility through two possible pathways. First, ROS 
peroxidize the polyunsaturated fatty acids in the sperm plasma membrane, leading to loss of membrane 
fluidity and integrity and, consequently, reduced motility(164). Second, excess ROS can damage 




mitochondrial membrane potential has been associated with reduced sperm motility(166), as ATP is 
required to power and sustain flagellation(167). Rather than having a critical period effect on motility, the 
association between overweight and obesity in participants’ 20s with reduced motility is likely due to the 
cumulative effect of obesity and resulting oxidative stress. Because most men gained weight between 
their 20s and 40s or maintained a BMI ≥25 kg/m2 (out of 184 who had BMI measures at all three time 
points, only 41 retained a normal BMI throughout adulthood and 5 lost weight), those who were obese in 
their 20s were likely to be exposed to excess ROS for the longest period of time prior to semen collection. 
We noted a slightly weaker association between obesity and motility for BMI in participants’ 30s and the 
weakest association for current BMI. 
Our results for morphology were less clear, although as with motility, it appeared to be linked 
more closely to adult BMI than adiposity in childhood. This may be a reflection of the close relationship 
between motility and morphology: defects in sperm head, neck, and tail all have the potential to adversely 
affect sperm motility(168). Sperm heads are shaped in a complex interaction between the developing 
spermatid and the “nurse” Sertoli cell. First, the round spermatid cell nestles into a specialized region of 
the Sertoli cell’s plasma membrane. Then an elongated scaffold of microtubules and F-actin hoops 
anchored to the endoplasmic reticulum of the Sertoli cell is formed around the spermatid and squeezes it 
into the characteristic oval sperm-head shape. Meanwhile, the Golgi apparatus in the Sertoli cell 
produces two types of vesicles: 1) acrosomal vesicles, which are transported via scaffold microtubules to 
the top of the spermatid nucleus, where they fuse to form the acrosome, and 2) non-acrosomal vesicles, 
which are transported to the opposite end of the spermatid, the location of the centrosome, where they 
contribute to tail development(115). While details of the spermatid head-shaping mechanism are still not 
completely understood, it is possible that the dysregulation of reproductive hormones associated with 
obesity, known as hyperestrogenic hypogonadotropic hypoandrogenemia(113), could interfere with its 
regulation. Furthermore, because of the important role that the Sertoli cell membrane plays in the shaping 
process, any obesity-induced increase in ROS that weakens the membrane’s lipid structure could also 






This study has several strengths. Because of the unique nature of the SER follow-up to the 
CHDS, it is the only study that we know of that has ever been able to explore the relationship of adiposity 
over the life course to semen quality in middle age. Having this rich resource allowed us to consider 
multiple life course models and discern between early life and adult influences on all three common 
semen quality parameters. Because of the in-depth interview of SER participants, we were able to adjust 
for a range of covariates, including demographic, behavioral, and psychosocial factors. Outcome 
misclassification was minimized, as semen collection and analysis followed a validated protocol and was 
carried out in the same laboratory that participated in the National Institute of Child Health and Human 
Development-funded National Cooperative Reproductive Medicine Network (Fertile Male Study)(169). 
Mean concentration and motility values in our sample are comparable to several other studies conducted 
among men drawn from the general population(54, 84, 100), enhancing generalizability. (We were unable 
to find comparable studies that reported mean percent morphology according to strict criteria.) 




Many of our findings were of borderline statistical significance, reflecting our limited sample size, 
which was restricted due to the expense involved in tracing participants who had not been contacted for 
more than 30 years and the challenge of recruiting men willing to provide semen samples. We also 
lacked childhood adiposity measures beyond 4 years of age; ideally we would have had additional data 
points in puberty and adolescence that would have allowed us to explore these potentially critical periods 
and provide a more continuous picture of adiposity across the life course. Because of the overall increase 
in child adiposity between 1970 and 2000 in the US(170), our use of the 2000 CDC growth charts was 
likely a source of nondifferential exposure misclassification, which would bias our results toward the null. 
Reliance on recalled weight during participants’ 20s and 30s could also be a source of exposure 
misclassification, but studies of recalled weight among middle-age men in the United States(171) and 




resulting bias would therefore be minimal and toward the null.    
 
2.5.3 Conclusion 
Our findings add nuance and complexity to the debate over the relationship of adiposity to semen 
quality. We found a statistically significant positive association between bw/ga and sperm concentration 
and increasingly negative associations between childhood adiposity measures and sperm concentration, 
especially among those in the overweight and obese categories. Adiposity in adulthood, but not 
childhood, was associated with percent progressive motility, with strongest associations seen for those 
who were obese in their 20s. Additional life course studies of adiposity and semen quality in larger 
cohorts are warranted to confirm these results and expand them to include the important developmental 
periods of puberty and adolescence. In addition, longitudinal studies that collect semen samples at 
multiple time points beginning in adolescence would provide important information on the natural 
progression of sperm concentration, motility, and morphology, and provide the opportunity to explore 
whether interventions such as exercise and weight loss might improve semen quality. Our results provide 
a compelling reason for clinicians to emphasize the importance of maintaining a healthy body weight both 
to their adult male patients and to the parents of young boys, as doing so may help prevent a diagnosis of 





































































































































   

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.3. Critical period models regressing semen parameters on adiposity measures. 
A. Sperm concentration 
Square-root sperm concentration (x 103/mL) 
  
Model 1 
beta* 95% CI 
Model 2 
beta* 95% CI 
Model 1 n=153 n=140 
wt/ht 4 months 0.00 -0.02, 0.02 -0.01 -0.03, 0.01 
bw/ga 0.01 -0.01, 0.03 0.01 -0.01, 0.03 
Model 2 n=142 n=129 
wt/ht 12 months 0.02 -0.01, 0.04 0.02 -0.00, 0.05 
wt/ht 4 months -0.01 -0.04, 0.02 -0.03 -0.05, 0.00 
bw/ga 0.01 -0.01, 0.03 0.01 -0.01, 0.03 
Model 3 n=132 n=120 
ssBMI 4 years -0.01 -0.04, 0.02 -0.01 -0.04, 0.02 
wt/ht 12 months 0.02 -0.01, 0.05 0.03 -0.00, 0.05 
wt/ht 4 months -0.00 -0.03, 0.02 -0.02 -0.05, 0.01 
bw/ga 0.00 -0.02, 0.03 0.01 -0.01, 0.03 
Model 4 n=128 n=120 
BMI 20s -0.01 -0.19, 0.18 -0.01 -0.20, 0.17 
ssBMI 4 years -0.01 -0.04, 0.02 -0.01 -0.04, 0.02 
wt/ht 12 months 0.02 -0.01, 0.05 0.03 -0.00, 0.05 
wt/ht 4 months -0.00 -0.03, 0.02 -0.02 -0.05, 0.01 
bw/ga 0.01 -0.02, 0.03 0.01 -0.01, 0.03 
Model 5 n=128 n=120 
BMI 30s -0.12 -0.36, 0.12 -0.07 -0.32, 0.17 
BMI 20s 0.12 -0.20, 0.44 0.06 -0.26, 0.39 
ssBMI 4 years -0.01 -0.04, 0.02 -0.01 -0.04, 0.02 
wt/ht 12 months 0.02 -0.01, 0.05 0.03 -0.00, 0.05 
wt/ht 4 months -0.01 -0.04, 0.02 -0.02 -0.05, 0.01 
bw/ga 0.01 -0.02, 0.03 0.01 -0.01, 0.03 
Model 6 n=127 n=119 
current BMI 0.09 -0.09, 0.27 0.01 -0.18, 0.20 
BMI 30s -0.18 -0.45, 0.09 -0.08 -0.35, 0.20 
BMI 20s 0.09 -0.24, 0.41 0.06 -0.27, 0.39 
ssBMI 4 years -0.01 -0.04, 0.02 -0.01 -0.04, 0.02 
wt/ht 12 months 0.02 -0.01, 0.05 0.02 -0.01, 0.06 
wt/ht 4 months -0.01 -0.04, 0.02 -0.02 -0.05, 0.01 
bw/ga 0.01 -0.01, 0.03 0.01 -0.01, 0.03 
 Bw/ga: sex-specific birth weight for gestational age percentile; wt/ht: sex-specific height-for-age 
percentile; ssBMI: sex-specific BMI percentile; BMI: body mass index 
*Model 1 covariate-unadjusted; Model 2 adjusted for age, race, abstinence, hormones, employment/job 
strain, age (days) at 4 months, age (days) at 12 months 





% Progressive motility 
  
Model 1 
beta* 95% CI 
Model 2 
beta* 95% CI 
Model 1 n=153 n=140  
wt/ht 4 months -0.02 -0.12, 0.07 -0.05 -0.15, 0.05 
bw/ga 0.02 -0.06, 0.11 0.03 -0.07, 0.13 
Model 2 n=142 n=129 
wt/ht 12 months -0.06 -0.17, 0.06 -0.04 -0.15, 0.08 
wt/ht 4 months 0.02 -0.10, 0.14 -0.03 -0.15, 0.09 
bw/ga 0.02 -0.07, 0.12 0.02 -0.08, 0.12 
Model 3 n=132 n=120 
ssBMI 4 years 0.01 -0.12, 0.14 -0.02 -0.15, 0.11 
wt/ht 12 months -0.04 -0.18, 0.09 -0.01 -0.15, 0.13 
wt/ht 4 months 0.05 -0.08, 0.17 0.00 -0.13, 0.13 
bw/ga 0.01 -0.09, 0.11 0.01 -0.10, 0.12 
Model 4 n=128 n=122 
BMI 20s -0.27 -1.14, 0.59 -0.16 -1.05, 0.74 
ssBMI 4 years 0.02 -0.12, 0.16 -0.01 -0.16, 0.13 
wt/ht 12 months -0.04 -0.18, 0.10 -0.01 -0.15, 0.13 
wt/ht 4 months 0.05 -0.09, 0.18 -0.00 -0.13, 0.13 
bw/ga 0.02 -0.08, 0.12 0.01 -0.10, 0.12 
Model 5 n=128 n=122 
BMI 30s -0.23 -1.37, 0.91 -0.07 -1.26, 1.11 
BMI 20s -0.03 -1.52, 1.46 -0.08 -1.64, 1.49 
ssBMI 4 years 0.02 -0.12, 0.16 -0.01 -0.16, 0.13 
wt/ht 12 months -0.05 -0.19, 0.09 -0.01 -0.15, 0.13 
wt/ht 4 months 0.04 -0.09, 0.18 -0.00 -0.13, 0.1 
bw/ga 0.02 -0.08, 0.13 0.01 -0.10, 0.12 
Model 6 n=127 n=119 
current BMI -0.01 -0.84, 0.83 0.11 -0.73, 0.95 
BMI 30s -0.22 -1.49, 1.05 -0.15 -1.47, 1.17 
BMI 20s -0.03 -1.56, 1.50 -0.11 -1.72, 1.50 
ssBMI 4 years 0.02 -0.12, 0.16 -0.01 -0.16, 0.13 
wt/ht 12 months -0.05 -0.19, 0.10 -0.02 -0.16, 0.13 
wt/ht 4 months 0.04 -0.10, 0.17 -0.00 -0.14, 0.13 
bw/ga 0.03 -0.08, 0.13 0.01 -0.10, 0.12 
Bw/ga: sex-specific birth weight for gestational age percentile; wt/ht: sex-specific height-for-age 
percentile; ssBMI: sex-specific BMI percentile; BMI: body mass index 
*Model 1 covariate-unadjusted; Model 2 adjusted for age, race, abstinence, education, income, smoking, 
exercise, employment, Perceived Stress Scale, Life Events Inventory, Center for Epidemiologic Studies 






% Normal morphology 
  
Model 1 
beta* 95% CI 
Model 2 
beta* 95% CI 
Model 1 n=152 n=141 
wt/ht 4 months 0.01 -0.02, 0.03 -0.00 -0.03, 0.02 
bw/ga -0.01 -0.04, 0.01 -0.01 -0.04, 0.02 
Model 2 n=141 n=130 
wt/ht 12 months 0.01 -0.03, 0.04 0.02 -0.01, 0.05 
wt/ht 4 months 0.00 -0.03, 0.04 -0.02 -0.05, 0.02 
bw/ga -0.01 -0.04, 0.01 -0.01 -0.04, 0.02 
Model 3 n=131 n=121 
ssBMI 4 years -0.00 -0.04, 0.03 -0.01 -0.04, 0.03 
wt/ht 12 months 0.00 -0.03, 0.04 0.02 -0.02, 0.06 
wt/ht 4 months 0.01 -0.03, 0.04 -0.01 -0.05, 0.02 
bw/ga -0.01 -0.04, 0.01 -0.01 -0.04, 0.02 
Model 4 n=127 n=121 
BMI 20s 0.22 -0.00, 0.44 0.18 0.04, 0.41 
ssBMI 4 years -0.01 -0.05, 0.02 -0.02 -0.05, 0.02 
wt/ht 12 months 0.01 -0.03, 0.04 0.02 -0.02, 0.06 
wt/ht 4 months 0.01 -0.03, 0.04 -0.01 -0.05, 0.03 
bw/ga -0.01 -0.04, 0.01 -0.01 -0.04, 0.02 
Model 5 n=127 n=121 
BMI 30s -0.06 -0.36, 0.24 -0.03 -0.35, 0.28 
BMI 20s 0.28 -0.10, 0.67 0.22 -0.19 0.62 
ssBMI 4 years -0.01 -0.05, 0.03 -0.01 -0.05, 0.02 
wt/ht 12 months 0.01 -0.03, 0.04 0.02 -0.02, 0.06 
wt/ht 4 months 0.01 -0.03, 0.04 -0.01 -0.05, 0.03 
bw/ga -0.01 -0.04, 0.01 -0.01 -0.04, 0.02 
Model 6 n=126 n=120 
current BMI 0.16 -0.06, 0.37 0.21 -0.01, 0.43 
BMI 30s -0.16 -0.49, 0.16 -0.17 -0.51, 0.17 
BMI 20s 0.23 -0.17, 0.62 0.15 -0.26, 0.56 
ssBMI 4 years -0.01 -0.05, 0.03 -0.01 -0.05, 0.02 
wt/ht 12 months 0.00 -0.04, 0.04 0.02 -0.02, 0.05 
wt/ht 4 months 0.01 -0.02, 0.05 -0.01 -0.04, 0.03 
bw/ga -0.01 -0.04, 0.01 -0.01 -0.04, 0.02 
 Bw/ga: sex-specific birth weight for gestational age percentile; wt/ht: sex-specific height-for-age 
percentile; ssBMI: sex-specific BMI percentile; BMI: body mass index 
*Model 1 covariate-unadjusted; Model 2 adjusted for age, race, abstinence, smoking, alcohol, 
employment, Perceived Stress Scale, Life Events Inventory, age (days) 4 months, age (days) 12 months 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.1. Participants in the SER follow-up to the CHDS included in the current analysis. 
 
 
SER: Study of the Environment and Reproduction; CHDS: Child Health and Development Studies 
*Attempted contact 




















































































































































































































































































































































































































































































































































































































































































































Supplemental Table 2.2: Creation of childhood and adulthood trajectory variables. 
 
In order to determine categories for the child and adult trajectory analyses, we first determined how many 
participants changed adiposity category between 4 months and 4 years, or between their 20s and when 
the Study of the Environment and Reproduction was conducted. 
 
Changes in child adiposity levels using 
weight-for-height percentile Changes in adult BMI levels 



















0 overweight-->morbidly obese 10 
overweight-->obese 
 














   
  morbidly obese-->morbidly obese 1 
   
  morbidly obese-->obese 0 
   
  morbidly obese-->overweight 0 
   
  morbidly obese-->normal 0 
   
  obese-->overweight 
 
2 
   
  obese-->normal 
 
0 
   








Normal: <85%ile; overweight: ≥85 and 
<95%ile; obese: ≥95%ile 
Normal: BMI <25 kg/m2; overweight: BMI ≥25 
and <30 kg/m2; obese: BMI ≥30 and <35 
kg/m2; morbidly obese: ≥35 kg/m2 
BMI: body mass index 
 
 
We then grouped the child adiposity trajectories into three categories: maintained (yellow), increased 
(pink), and reduced (green), with maintained used as the reference category in regression analysis. We 
also grouped the adult adiposity trajectories into three categories. The reference category was those who 
maintained a normal BMI (yellow). The contrasting categories were those who had normal BMI in their 
20s but >normal at the time of the study (blue); those who were overweight or obese in their 20s and 
became obese or morbidly obese, respectively (pink); and those who had >normal BMI in their 20s and 
either maintained or reduced (green). Results did not change when we performed sensitivity analyses of 




Supplemental Table 2.3. Semen outcomes by levels of potential covariates. 
 





  n mean (SD) n mean (SD) n mean (SD) 
Race       *   * 
White 110 73.2 (52.7) 110 41.3 (16.2) 109 7.3 (4.1) 
Black 46 68.5 (57.5) 46 32.3 (14.5) 46 6.6 (3.9) 
Other 37 81.4 (76.2) 37 43.3 (15.1) 37 9.5 (4.2) 
Education             
≤High school 35 92.8 (87.4) 35 34.0 (17.0) 35 8.0 (4.7) 
Some college 71 74.2 (55.2) 71 41.9 (15.6) 71 7.5 (4.4) 
Bachelors degree 57 59.9 (40.3) 57 40.4 (13.9) 57 7.4 (3.9) 
Graduate level 22 73.9 (57.1) 22 42.3 (19.2) 21 7.7 (4.2) 
Income (x US$1,000)       *     
≤ 50 55 81.1 (77.5) 55 35.5 (17.4) 55 7.2 (4.5) 
50-99 64 74.7 (43.0) 64 41.6 (15.6) 63 8.2 (4.2) 
100-149 31 62.8 (58.5) 31 45.0 (16.3) 31 7.6 (4.5) 
≥ 150 30 57.0 (35.5) 30 41.3 (12.8) 30 7.0 (3.7) 
Smoking       *     
Current 33 83.6 (86.9) 33 30.8 (15.1) 33 6.3 (3.9) 
Never/ever 152 71.0 (52.1) 152 42.0 (15.5) 151 7.9 (4.3) 
Employment status       *   * 
Employed 159 75.9 (59.0) 159 41.7 (15.3) 158 7.9 (4.2) 
Unemployed 26 57.4 (63.1) 26 29.2 (15.9) 26 5.9 (4.3) 
Hormone use             
Yes 177 74.5 (60.2) 177 40.0 (16.0) 176 7.7 (4.2) 
No 3 22.2 (9.3) 3 45.7 (2.5) 3 3.8 (1.4) 
Life Events Inventory       *   * 
0 95 70.8 (53.7) 95 42.5 (15.3) 94 8.3 (4.1) 
1 49 78.9 (46.8) 49 42.1 (16.3) 49 7.4 (3.7) 
2 or more 46 74.7 (79.2) 46 33.2 (15.1) 46 6.4 (4.7) 
Job strain             
Low 126 76.5 (62.9) 126 42.6 (15.3) 125 7.9 (4.3) 
High 36 75.6 (51.1) 36 39.7 (15.7) 36 7.3 (3.7) 
    corr   corr   corr 
Age (years) 193 -0.20* 193 -0.26* 192 -0.20* 
Alcohol (g/week) 182 0.01 182 0.06 181 0.004 
Caffeine (mg/week) 185 0.07 185 0.13 184 -0.07 
Exercise (minutes/week) 188 -0.01 188 -0.13 187 -0.08 
Perceived Stress Scale 190 -0.11 190 -0.18* 189 -0.19* 
CES-D 188 -0.06 188 -0.23* 187 -0.11 
Abstinence time (minutes) 193 0.19* 193 -0.08 192 0.05 
CES-D: Center for Epidemiologic Studies Depression scale; corr: Spearman correlation coefficient 




Supplemental Table 2.4. Spearman correlations among semen parameters. 
 
Semen 
outcome 1 2 3 
1 Sperm concentration     
correlation 1     
p-value       
n 193     
2 % Progressive motility   
correlation 0.37 1   
p-value <0.0001     
n 193 193   
3 % Normal morphology 
correlation 0.52 0.43 1 
p-value <0.0001 <0.0001   





Supplemental Table 2.5. Spearman correlations among bw/ga and adiposity measures. 
  1 2 3 4 5 6 7 
1 bw/ga 
      correlation 1 
      p-value   
      n 193   
     2 wt/age 4 months 
     correlation 0.47 1 
     p-value <.0001   
     n 153 153 
     3 wt/age 1 year 
    correlation 0.40 0.67 1 
    p-value <.0001 <.0001   
    n 152 142 152 
    4 ssBMI 4 years 
   correlation 0.15 0.35 0.49 1 
   p-value 0.05 <.0001 <.0001   
   n 160 140 141 160   
  5 BMI in 20s 
  correlation 0.08 0.05 0.11 0.23 1 
  p-value 0.27 0.53 0.18 0.004   
  n 185 148 146 153 185   
 6 BMI in 30s 
 correlation 0.09 0.08 0.10 0.19 0.84 1 
 p-value 0.24 0.31 0.22 0.02 <.0001   
 n 185 148 146 153 185 185   
7 current BMI 
correlation 0.04 0.12 0.16 0.21 0.69 0.80 1 
p-value 0.54 0.15 0.06 0.01 <.0001 <.0001   
n 189 150 148 157 184 184 189 
 
Bw/ga: sex-specific birth weight for gestational age percentile; wt/ht: sex-specific height-for-age 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Figure 2.1. Hypothesized relationships between adiposity, semen quality, and 




Bw/ga: sex-specific birth weight for gestational age percentile 








Supplemental Figure 2.2. Percentage of participants meeting 0, 1, 2, or 3 World Health 



















Supplemental Figure 2.3. Histograms of semen quality outcome measures.  
 
A. Sperm concentration 
 
B. Percent progressive motility 
 





Supplemental Figure 2.4. Covariate-adjusted* loess smoothing curves of percent normal motility 
vs. adult BMI at three time points. 
A. BMI in 20s 
 
B. BMI in 30s 
 
C. Current BMI 
 
BMI: body mass index 
*adjusted for birth weight for gestational age, current age, race, abstinence time, education, income, 
smoking, exercise, Perceived Stress Scale, Life Events Inventory, Center for Epidemiologic Studies 




Supplemental Figure 2.5. Percentage of low progressive motility according to World Health 
Organization criteria by category of adult BMI at three time points. 
A. BMI in 20s 
 
Chi-square Fisher’s exact test p-value = 0.02 
Two-sided exact Cochran-Armitage trend test p-value = 0.02 
B. BMI in 30s 
 
Chi-square Fisher’s exact test p-value = 0.23 
Two-sided exact Cochran-Armitage trend test p-value = 0.13 
C. Current BMI 
 
Chi-square Fisher’s exact test p-value = 0.43 
Two-sided exact Cochran-Armitage trend test p-value = 0.15 
 












BMI level: 1=normal, 2=overweight, 3=obese 












BMI level: 1=normal, 2=overweight, 3=obese 












BMI level: 1=normal, 2=overweight, 3=obese, 
4=morbidly obese 




CHAPTER 3. A PILOT STUDY OF THE RELATIONSHIP BETWEEN ALLOSTATIC LOAD AND SEMEN 
QUALITY IN AN URBAN FERTILITY CLINIC 
 
3.1 ABSTRACT 
Introduction: Psychosocial stress has been identified as a risk factor for poor semen quality, but most 
studies have examined only subjective or objective measures of recent stress and have consequently 
been limited in their ability to explore the biological relationship between stress and semen quality or the 
potential impact of cumulative stress over the life course on sperm production. 
Objectives: We tested whether allostatic load, a biologically-based construct that theoretically reflects the 
effect of accumulated stress on the body’s major regulatory systems, is associated with sperm 
concentration, percent progressive motility, and percent normal morphology in men recruited from an 
urban fertility clinic. 
Methods: In this cross-sectional pilot study, 61 English-speaking, non-azoospermatic men, age 27 to 53 
years, who were part of couples seeking fertility treatment at Columbia University’s Center for Women’s 
Reproductive Care completed a questionnaire, had weight and blood pressure measured, and provided 
blood and semen samples for analysis. An allostatic load scale was created using 10 biomarkers of 
cardiovascular, metabolic, hypothalamus-pituitary-adrenal axis, and immune system function. Regression 
was performed to assess associations between allostatic load and sperm concentration, percent 
progressive motility, and percent normal morphology, controlling for covariates. Partial Spearman 
correlations were used to examine associations between metabolic and non-metabolic subdomains of 
allostatic load and the three semen outcomes. 
Results: Allostatic load was not associated with sperm concentration or percent normal morphology in 
our sample. Those with ≥1 allostatic load indicators had on average 17.71 (95% CI [6.03, 29.38]) points 
higher percent progressive motility than those with no allostatic load indicators, adjusting for covariates. 
This relationship appeared to be driven by the 6 subjects in the lowest allostatic load category, who 
differed from the rest on mean testosterone level and possibly other unmeasured variables. The 




concentration and motility after adjustment for covariates, but there was no correlation with the non-
metabolic subdomain. 
Conclusion: This pilot study suggests that the relationship between cumulative stress, operationalized as 
allostatic load, and semen quality may differ from that of recent stress, and that metabolic function may 








Poor semen quality is the primary diagnostic criterion for male infertility. Its predictors are multiple 
and incompletely understood. Male factor infertility affects approximately 50 percent of the 7.3 million 
couples facing involuntary childlessness in the United States(7), contributing to the increasing use of 
costly assisted reproduction technologies(8). Psychosocial stress has been identified as a risk factor for 
poor semen quality (summarized in (173, 174)), but empirical results have been inconsistent. Most 
studies have examined only subjective or objective measures of stress and have consequently been 
limited in their ability to explore the biological relationship between stress and semen quality. They have 
also considered only recent stress exposure, and have not explored the potential impact of cumulative 
stress over the life course on sperm production. Repeated or chronic stress can become biologically 
“embedded,” as it has been shown to structurally remodel parts of the brain, thereby altering production of 
stress hormones and cytokines that affect various physiological systems (reviewed in (175)). In this cross-
sectional pilot study, we aimed to fill these gaps by testing whether allostatic load, a biologically-based 
construct that theoretically reflects the effect of accumulated stress on the body’s major regulatory 
systems, is associated with sperm concentration, percent progressive motility, and percent normal 
morphology in men recruited from an urban fertility clinic.  
Over the past three decades, a growing body of literature has suggested that acute or recent 
psychosocial stress may be inversely associated with sperm concentration, motility, and morphology, but 
study results have not been consistent, with many reporting no association(129, 151, 174, 176-204). A 
major source of that variability is the diversity of exposure measures used to capture the construct of 
stress. Many of these studies did not measure stress at all, but instead measured anxiety or depression 
using tools such as the Spielberger State-Trait Anxiety Inventory(179, 186, 196, 202), Zung’s Anxiety 
Scale Inventory(204), and the Hospital Anxiety Depression Score(177). Others measured subjective 
psychosocial stress using stand-alone questions(129, 183, 195) or validated scales such as the 
Perceived Stress Scale(151, 192), the General Health Questionnaire(190), the Life Stress 
Questionnaire(184), or the Copenhagen Psychosocial Questionnaire(174). Job-related stress was 
captured through direct questions(178, 183) or validated scales such as the Job Content 




Fragebogen zur Abschätzung des Psychosomatischen Krankheitsgeschehens(191). To assess objective 
stress, researchers had subjects tally recent acutely stressful life events(151, 182, 185, 204) or designed 
studies around specific stressful events, including medical exams(181, 194, 198), war(176, 203), or an 
earthquake(205). To measure stress specific to infertility, one group created an Infertility Distress 
Scale(199, 200), another used the Fertility Problem Inventory(197), while still others captured the stress 
of providing a semen sample for in vitro fertilization by comparing results of a previous diagnostic semen 
analysis to an analysis done on the day of the female partner’s egg retrieval(180, 187, 188, 193, 201).  
In addition to the various means of operationalizing stress used in these studies, the lack of 
consistency among their results may be attributable to several other factors, including a wide range of 
sample sizes and study populations, and inconsistent covariate control (Supplemental Table 3.1). Sample 
sizes ranged from 15 (in a study of medical students before and during exams)(194) to 10,782 (in a study 
of Lebanese men during and after the civil war)(176). Some studies included only men recruited from 
fertility clinics or andrology labs who were part of infertile couples(176-180, 183, 186-188, 191-193, 197, 
199-201, 203-205), others sampled only men known to be fertile(129, 185), while still others sampled 
men from the general population(151, 182, 184, 195, 196). Most studies included men whose ages 
spanned the childbearing years, while others focused on exclusively young men such as military 
recruits(174), medical students(181, 194, 198), and first-time pregnancy planners(189, 190). The 
divergent sampling pools of these studies limit not only the generalizability of their results, but their ability 
to be compared to one another. Finally, fewer than half of the 33 analyses we reviewed adjusted for any 
covariates, and only 11 adjusted for both age and duration of abstinence prior to semen collection, one of 
several proposed criteria for high-quality semen studies(58). 
All of these prior studies only consider the role of recent stress, most often in or around the 74-
day period of spermatogenesis(41), and do not account for the potential of cumulative stress over the life 
course to affect regulatory systems in the body that may support healthy sperm production, including 
cardiovascular function, metabolism, hypothalamus-pituitary-adrenal (HPA) axis activity, and 
inflammation. Persistent exposure to stress may compromise the ability of these systems to appropriately 
respond to or recover from a stressful experience and regain homeostasis. This maladaptation causes 




Eyer coined to describe this process of re-equilibration(206). Even if two men experience similar stressful 
events, their physiologic responses—how they embody that stress--may differ according to how they 
perceive it as well as how much allostatic load they have accumulated over their life course, both of which 
are influenced by prior stress exposure. 
The concept of an allostatic load scale to capture the degree of homeostatic dysregulation was 
pioneered by Seeman et al. in their analysis of the MacArthur studies of successful aging, in which they 
created a 0-10 point scale to measure levels of allostatic load using parameters of physiologic activity 
across a range of domains associated with disease risk(44). Their scale included seven biomarkers (total 
cholesterol, high density lipoprotein (HDL), cortisol, epinephrine, norpeinephrine, glycosylated 
hemoglobin (HbA1c), and dehydroepiandrosterone sulfate (DHEA-S)) and three anthropometric 
measures (systolic and diastolic blood pressure, and waist-hip ratio). Each variable was dichotomized 
and one point was given to those in the highest risk quartile according to its distribution in the study 
sample. In a subsequent paper, Seeman et al. suggested adding C-reactive protein (CRP) and 
interleukin-6 (IL-6) to the scale in order to capture disturbance of the inflammatory response, an important 
adaptive process(207). 
In the cardiovascular literature, there has been debate as to whether or not the construct provides 
additional information beyond the effect of metabolic syndrome alone, as several of the diagnostic criteria 
of metabolic syndrome such as abdominal obesity, low HDL cholesterol, and elevated triglycerides, blood 
pressure, and blood sugar are frequently included in allostatic load scales(44, 208-210). There is some 
evidence that metabolic syndrome may be associated with male infertility, as well(211, 212), potentially 
prompting a similar concern about hypothesizing an association between allostatic load and poor semen 
quality. Furthermore, it is possible that while some semen parameters may be more strongly affected by 
increased allostatic load in systems affiliated with metabolism, others may be more strongly affected by 
increased allostatic load in regulatory systems classified as non-metabolic, such as inflammation. Indeed, 
studies have shown elevated seminal plasma levels of inflammatory cytokines such as IL-6 to be 
associated with male infertility(213, 214). 
We hypothesized that increased total allostatic load would be associated with lower sperm 




non-metabolic subdomains of the allostatic load scale would have different effects on the three semen 
parameters. Our purpose was to increase understanding of the biological mechanisms by which stress 
influences the male reproductive system and suggest potential avenues for clinical management of men 




The pilot study sample comprised 61 non-azoospermatic men (i.e., not lacking sperm in their 
semen), mean age 38.9 years, who were of unknown fertility status but were part of couples seeking 
fertility treatment at Columbia University’s Center for Women’s Reproductive Care (CWRC) in midtown 
Manhattan. Because of budget restrictions, sampling was restricted to English speakers. Participants 
were required not to have previously undergone semen analysis and to be providing both semen and 
blood samples on the day of the visit. Basic demographic features of the study population are presented 
in Table 3.1. 
 
3.3.2 Procedures 
Between May and December, 2014, eligible participants were sequentially recruited when they 
arrived at CWRC for their initial fertility workup. If they agreed to participate, they provided informed 
consent and filled out a 48-item self-administered written questionnaire that included self-reported height. 
Participants then provided a semen sample and, afterward, had nonfasting blood samples drawn as part 
of the standard infertility workup protocol; for research purposes, an additional two vials of blood were 
collected and weight and blood pressure were taken by trained clinic staff using a Detecto 439 Physician 
Beam Scale and Welch Allyn 300 Series Vital Signs Monitor, respectively. All non-fasting blood samples 
were collected between 9:40 am and 12:30 pm. 
Semen samples were analyzed according to the 2010 World Health Organization (WHO) 
protocol(145) at the CWRC lab. Briefly, subjects produced semen samples by masturbation into sterile 




sample was immediately transferred to the on-site diagnostic laboratory, where it was analyzed within 1 
hour of collection by one of two trained andrologists. Upon liquefaction, volume was measured by weight, 
viscosity was determined, and pH was tested. After thorough mixing, one drop (3-5 µl) of semen was 
used to fill the two chambers of a calibrated MicroCell disposable counting chamber (Conception 
Technologies, San Diego, CA), and another drop was placed on a Fisherfrost Superfrost microscope slide 
(Fisher Scientific), tightly cover slipped to achieve a thin layer, and set aside for at least 15 minutes. 
Using a phase contrast microscope to observe the sample in one of the MicroCell chambers, sperm 
aggregation and agglutination were assessed and the concentration of non-spermatozoa (“round cells”) 
was determined. With an eyepiece reticle fitted to the microscope and calibrated with a stage micrometer, 
100 sperm were subsequently counted at x200 or x400 magnification and the number of grids containing 
the sperm were noted so that total sperm count and sperm concentration could be calculated. This 
procedure was repeated in the second MicroCell chamber. Motility was assessed by grading the 
movement of 100 spermatozoa in each of the two chambers as progressive, non-progressive, or 
immotile. For sperm count and motility, if there was <10% difference between the duplicate measures, the 
average measure was used. If there was >10% difference, the entire procedure was repeated. To assess 
morphology, the prepared slide was observed under oil at x1000 magnification and 100 sperm were 
appraised. Head, midpiece, and tail all had to be normal for a spermatozoon to be considered normal; 
any borderline forms were considered abnormal, according to Kruger’s strict criteria(215). 
Blood samples taken for the fertility workup were analyzed at CWRC for communicable diseases; 
blood samples taken for research purposes were refrigerated and transported to Columbia University 
Medical Center’s Clinical and Translational Science Award (CTSA) Core Biomarkers Laboratory within 4 
hours of collection, where they were aliquoted and frozen at -80°C prior to having allostatic load 
biomarkers and testosterone levels analyzed. The research protocol was approved by the Institutional 
Review Board of Columbia University. 
 
3.3.3 Exposure measures 
According to the methodology described by Seeman et al., an allostatic load scale was created 




body mass index (BMI), systolic and diastolic blood pressure, total cholesterol, HDL cholesterol, albumin, 
CRP, HbA1c, DHEA-S, and IL-6(44) (see Supplemental Table 3.2 for assay descriptions). Table 3.2 
shows the regulatory systems represented by the various indices along with each component’s sample 
median, range, mean, standard deviation, and high-risk quartile cutoff point, as well as the clinical cut 
point above or below which is considered abnormal and the percent of subjects with values beyond the 
clinical cut point. Men who reported taking cholesterol- or blood pressure-lowering medication were 
classified as high risk for those measures. Allostatic load was modeled both as a count variable and 
dichotomously in order to describe the pattern of its association with the outcome measures. For 
purposes of sensitivity analyses, an alternate allostatic load scale was created using clinical rather than 
sample-based quartile cut points for the 10 components. Scales were also created that represented the 
metabolic (cardiovascular and metabolism) and non-metabolic (HPA axis and inflammation) subdomains 
of allostatic load. 
 
3.3.4 Outcome measures 
The three semen parameters—sperm concentration, percent progressive motility, and percent 
normal morphology--were modeled both as continuous variables and dichotomously using 2010 WHO 
reference values for poor semen quality: sperm concentration <15 million/mL, percent progressive motility 
<32%, percent normal morphology <4%(147).  
 
3.3.5 Covariates 
Information on behavioral, sociodemographic, medical, and psychosocial risk factors for infertility 
were assessed via written questionnaire. Covariates identified as potential confounders based on a 
review of the literature and a causal diagram (directed acyclic graph) included: age (continuous, years), 
race (white vs. other), US birth (Y/N), education (high school or some college, bachelor’s degree, 
graduate level), income (<$100,000, $100,000-150,000, >$150,000), smoking status (current vs. not 
current), caffeine consumption (Y/N), alcohol consumption (Y/N), and exercise (any vs. none). Although 




surgery (Y/N), and diagnosis with a sexually transmitted infection (ever/never), do not meet the criteria for 
confounders, they were considered because of their potential contribution to the variance of the outcome 
measures.  
Allostatic load theoretically represents cumulative stress over the life course, but some of its 
components may be influenced by recent stress, so we also considered the following measures of current 
anxiety, stress, and depression: anxiety related to fertility treatment (Y/N), operationalized as the question 
“Were you ever concerned about a possible problem with your fertility?”; the validated abbreviated 10-
item Perceived Stress Scale (PSS) assessing feelings during the last month(152); a shortened form of the 
Life Events Inventory (LEI) assessing experiences during the last 3 months(153), which includes the top 
10 stressors of men from an occupational sample(154); the 16-item Job Content Questionnaire (JCQ) 
assessing job requirements and satisfaction during the last 3 months(155); and the 20-item Center for 
Epidemiologic Studies Depression Scale (CES-D) assessing feelings and experiences during the last 
week(156) (Supplemental Figure 3.1). PSS, LEI, and CES-D were modeled continuously; a dichotomous 
job strain variable was created that categorized those above the sample median job demand score and 
below the sample median job control score as high strain. Because BMI is one of the items in the 
allostatic load scale, it was not considered as a covariate in the regression models. 
 
3.3.6 Statistical analyses 
Univariate analyses were performed to describe characteristics of the cohort and to assess the 
distributions of the three outcome variables--sperm concentration, percent progressive motility, and 
percent normal morphology.  
In bivariate analyses, analysis of variance was used to compare means of the count/continuous 
exposure and outcome variables according to levels of potential categorical covariates. Chi-square tests 
were used to detect bivariate associations between categorical covariates. Nonparametric Spearman 
correlations were used to examine associations between potential continuous covariates as well as 
between continuous covariates and both exposure and outcome variables. Spearman correlations among 




We decided a priori to include age, time from ejaculation to semen analysis, and duration of 
ejaculatory abstinence in each of the final models. To select additional covariates for control in the 
regression models, separate simple linear regression models were run to examine the association 
between allostatic load score and each of the three outcome variables. Hypothesized confounders and 
predictors of the outcomes that changed the estimated regression coefficient of the predictor in the simple 
model by at least 50% of the standard error were included in the relevant covariate-adjusted models.  
Linear regression models with allostatic load as the quantitative predictor for the three continuous 
semen outcomes were run with and without covariates. Logistic regression models with allostatic load as 
the quantitative predictor for the three dichotomous semen outcome variables (based on WHO reference 
levels) were run with and without the same covariates as in the corresponding linear models. Boxplots of 
allostatic load score vs. each of the continuous semen parameters were created to visualize the direction 
and shape of the relationships. Bar graphs were created to show the relative percentage of subjects with 
semen variables below the WHO reference levels for each allostatic load score.  
In post-hoc analyses, where there appeared to be potential threshold effects, dichotomous 
allostatic load variables were created at the points suggested by the boxplots. To account for possible 
unequal variance in outcome within the allostatic load groups, we used linear models with 
heteroscedasticity-consistent standard errors(216, 217) to assess associations between binary allostatic 
load variables and the three semen outcomes, with and without covariates. Because of concern that 
recent psychosocial stress might contribute to allostatic load, in which case including stress variables in 
our models could bias the estimates of the associations through overadjustment(150), we compared 
results of the final covariate-adjusted models that had sperm concentration as the outcome to models 
without job strain (the only stress variable that met the criteria for inclusion in any of the final models). 
Additionally, when it appeared that those with an allostatic load score = 0 had substantially lower percent 
progressive motility than the rest, we compared results of the final covariate-adjusted models that had 
motility as the outcome to models that included only those with allostatic load ≥1. 
In alternative analyses, all regression models were repeated using allostatic load scores based 




Because the total allostatic load and its metabolic and non-metabolic subdomains contained 
different numbers of items, in secondary analyses we used covariate-adjusted partial Spearman 
correlations to describe the strength and direction of the associations among the three configurations of 
allostatic load and the three semen outcomes. We also examined whether each of the ten items of the 
total allostatic load scale, measured continuously, was correlated with the outcome measures. All 
analyses were performed in SAS 9.3 (SAS Institute, Cary, NC). 
 
3.4 RESULTS 
Allostatic load score, calculated using the sample cut points, was right-skewed, with a 
median/mode of 2 and a range of 0-7 out of 10 (using clinical cut points, median/mode = 1 and range = 0-
5 out of 10). There was weak to moderate correlation among the allostatic load items within the metabolic 
and non-metabolic subdomains (Supplemental Table 3.3). No extreme values were apparent in univariate 
analysis of the three outcome measures and upon visual inspection of histograms it was determined that 
they did not require transformation to meet the normality assumption for linear regression (Supplemental 
Figure 3.2). Mean sperm concentration was 47.4x10⁶/mL (standard deviation (SD) 29.0); mean percent 
progressive motility was 41.2 (SD 14.3); mean percent normal morphology was 2.3 (SD 1.7) (Table 3.1). 
The three semen parameters were significantly correlated with one another (range of correlation 
coefficients: 0.27-0.41) (Supplemental Table 3.4). 
Allostatic load was not associated with any of the current stress or depression scales in our 
model (Supplemental Table 3.5). 
In our sample, 13.1, 26.2, and 75.4 percent of participants were below the 2010 WHO reference 
values for sperm concentration, progressive motility, and normal morphology, respectively (Supplemental 
Figure 3.3). Only 18.0 percent of our sample was above the reference values for all three parameters 
(Supplemental Figure 3.4). Histograms of the three semen outcomes appeared approximately normally 
distributed. 
Boxplots of mean semen parameters for each allostatic load level suggested a potential threshold 
effect between clinic-based allostatic load score = 0 and ≥1 for concentration, between both sample- and 




load score ≤4 and ≥5 for morphology (Figure 3.1; note: the top two levels of allostatic load were collapsed 
because of sparse data in the highest level). 
 
3.4.1 Concentration 
In linear regression analyses, sample-based allostatic load score, modeled as a count variable, 
was not associated with sperm concentration in our data, regardless of whether we used sample-derived 
or clinical cut points. When we tested the clinic-based dichotomous allostatic load variable 0 vs. ≥1 to 
explore the potential threshold seen in the boxplot, we found that the 49 subjects with clinic-based 
allostatic load ≥1 had on average 17.52 million more sperm/mL (95% CI [1.38, 36.41]) compared to the 12 
subjects with allostatic load = 0 in regression analysis adjusting for covariates. When we did not adjust for 
job strain, the association was stronger (badj = 21.14, 95% CI [3.12, 39.16]). This suggests that job strain 
may contribute to allostatic load, as adjusting for it weakens the positive relationship between allostatic 
load and sperm concentration. In logistic regression analyses, there was no association between either 
sample-based or clinic-based allostatic load score and low sperm concentration according to the WHO 
reference value (Table 3.3). 
 
3.4.2 Motility 
Modeled as a count variable, sample-based allostatic load was not significantly associated with 
motility in linear regression analyses. When the sample-based allostatic load score was modeled 
dichotomously, the adjusted percent progressive motility was on average 17.71 (95% CI [6.03, 29.38]) 
points higher among the 55 subjects with an allostatic load score ≥1 compared to the 6 subjects with an 
allostatic load score of 0. When the clinic-based allostatic load count variable was used, there was a 
statistically significant positive relationship with motility (badj = 3.57, 95% CI [0.66, 6.48]). When the 12 
subjects with the lowest clinic-derived allostatic load score were removed, the association again 
disappeared (badj = 1.60, 95% CI [-1.56, 4.75]). When this model was run using the clinic-based 
dichotomous allostatic load variable, the 49 subjects with an allostatic load score ≥1 had on average 




with an allostatic load score of 0 in adjusted analyses. Using logistic regression, there was no association 
between sample-based or clinic-based allostatic load score and low percent progressive motility 
according to the WHO reference value (Table 3.3). 
 
3.4.3 Morphology 
In unadjusted and adjusted linear models, we found no association between either sample-based 
or clinic-based allostatic load score, modeled as a count variable, and sperm morphology. Using a 
sample-based dichotomous allostatic load variable suggested by the boxplot, the adjusted percent normal 
morphology was on average 1.10 (95% CI [0.12, 2.08]) points lower among the 10 subjects with an 
allostatic load score ≥5 compared to the 51 subjects with an allostatic load score ≤4. In logistic regression 
analyses, there was no association between sample-based or clinic-based allostatic load score and low 
percent normal morphology according to the WHO reference value (Table 3.3). 
Partial Spearman correlations were run between each of the semen outcomes and the total 
allostatic load score, its metabolic and non-metabolic subdomains, and the 10 individual components of 
allostatic load. While none of the outcomes was correlated with the sample-based total allostatic load 
score, sperm concentration and progressive motility were positively correlated with the metabolic 
subdomain and negatively but not statistically significantly correlated with the non-metabolic subdomain. 
Systolic blood pressure, HbA1c, and serum albumin were also positively correlated with sperm 
concentration, while BMI was positively but not significantly correlated with percent progressive motility. 
Percent normal morphology was not correlated with any of the allostatic load measures (Table 3.4). 
 
3.5 DISCUSSION 
 The results of our analyses do not support our hypothesis of an inverse relationship between 
allostatic load and sperm concentration, motility, and morphology, as has generally been observed in 
prior research on current stress and semen quality. Instead we found no association between allostatic 




motility. While it is possible that our results reflect differential effects of current and cumulative stress on 
semen parameters, there are several other potential explanations for these discrepancies.  
While the mean percent progressive motility in our sample was comparable to that in other 
infertility cohorts of similarly aged men, the mean sperm concentration was slightly lower(218). Percent 
normal morphology in our sample was also lower than that in other published studies conducted in 
infertility clinics that used strict criteria(219-221). These differences in distribution, coupled with our small 
sample size, may have diminished our ability to detect an association between allostatic load and sperm 
concentration and morphology. 
 Our results may also have been influenced by the distribution of allostatic load in our cohort. In 
most domains, our subjects were generally healthy, as few exceeded the clinical high-risk cutoffs for 
measures of cardiovascular, HPA axis, and inflammatory system function; however, between 20% and 
36% met each of the clinical high-risk criteria for impaired metabolic function (Table 3.2). Our cohort was 
of higher socioeconomic status than the general US population, as evidenced by the fact that all of our 
participants had health insurance, nearly three-quarters had at least a bachelor’s degree, and only 2 
earned less than $50,000/year (Table 3.1). They were also likely more advantaged than men included in 
studies that sampled from fertility clinics in countries where assisted reproduction is provided as part of 
national health systems and is not only available to those who can pay out of pocket or have health 
insurance that covers the procedure. Our participants’ overall health and lack of adversity is reflected in 
the low maximum allostatic load scores in our sample: 7 out of 10 and 5 out of 10 using sample-derived 
and clinical cut points, respectively. After 7 years of observing their cohort of substantially older US adults 
(age 70-79 at recruitment), Seeman et al. observed a nonlinear relationship between allostatic load and 
mortality as well as cognitive and physical functioning, with a notably increased effect in the top allostatic 
load category (a score of 7-10 out of 10)(210). If the effect of allostatic load on semen quality were 
similarly concentrated at the high end of the allostatic load spectrum, our study would not have been able 
to capture it. 
 Another possible explanation of the discrepancy between our results and others’ is that our 
allostatic load scale lacked measures of epinephrine, norepinephrine, and cortisol, all of which increase in 




sympathetic nervous system and HPA axis activity may indicate the biological mechanism that explains 
prior published findings of inverse associations between stress and semen quality. Furthermore, the 
serum biomarkers we did measure may not accurately reflect the chemical milieu in the testes, where 
sperm are produced. For example, concentrations of anti-Müllerian hormone, which is released by Sertoli 
cells in the testes, differ when measured in blood vs. semen; levels in seminal plasma have been found to 
be positively associated with sperm concentration, while there is no association with levels in serum(224). 
Similarly, levels of fatty acids, which have been shown to be associated with sperm morphology(225), 
differ between serum and seminal plasma(226, 227). It may be necessary to measure biomarkers of 
allostatic load in seminal plasma to accurately gauge the effect of homeostatic dysregulation on semen 
quality. As in all observational studies, there is also the possibility of residual confounding by unmeasured 
covariates. 
 Our finding of a positive association between allostatic load and progressive motility is driven by 
the 6 subjects with no allostatic load risk factors, who had significantly lower percent motile sperm than 
those in all other categories. Those subjects did not differ from the rest of the cohort on any of the 
hypothesized potential covariates; they did, however, have higher mean testosterone than the rest 
(523.33 ± 192.57 ng/dL vs. 391.82 ± 142.80 ng/dL) (Supplemental Table 3.6). Higher testosterone was 
significantly associated with lower progressive motility in the overall cohort, both including and excluding 
the 6 subjects. This is in contrast to published observational studies that have found either a positive 
association(177, 228, 229) or no association(80, 230-232) between testosterone and sperm motility. 
When testosterone was added to the adjusted model of the relationship between allostatic load and 
motility, the result was still significantly positive, but the estimated beta was slightly closer to the null (badj 
=13.62; 95% CI, 1.39, 25.86 vs. 17.71; 95% CI, 6.03, 29.38), suggesting potential partial mediation by 
testosterone. The remaining strength of the testosterone-adjusted relationship indicates either the 
presence of an unmeasured variable that distinguishes those in the lowest allostatic load category from 
the rest or is simply a spurious result due to our small sample size. 
 It is notable that the partial correlation coefficients of the metabolic and non-metabolic 
subdomains of allostatic load are in opposite directions in relation to sperm concentration and progressive 




is also notable that the individual allostatic load components that are most responsive to fluctuations in 
current conditions—systolic and diastolic blood pressure, HbA1c, and serum albumin—were most 
strongly and positively correlated with sperm concentration. The only component significantly associated 
with morphology was DHEA-S in men between ages 40 and 50, which suggests that as HPA axis activity 
decreases with age, effects on sperm morphology may become more pronounced (Table 3.4). When 
individual components of allostatic load that may be driving the total score (especially in a low-stress 
population) are responsive to recent stress, it begs the question of allostatic load’s validity as a construct 
for measuring the impact of cumulative stress on the body.  
In cases when biological processes and subsystems appear to work in sync to influence a 
particular health outcome, such as cardiovascular disease, associations between allostatic load and that 
health outcome may be stronger than those of individual markers, as seen in Seeman et al.’s analysis of 
the MacArthur Studies(44). In our study, by contrast, it appears that alterations in metabolic and non-
metabolic (primarily inflammatory) systems’ responses to stress may have opposing effects on semen 
quality, which are obscured when all components of the scale are combined, throwing into question the 
value of allostatic load as a unified construct. It is also possible that allostatic load reflects cumulative 
stress most reliably in older or highly stressed populations in which there are more subjects with total 
scores at the high end of the scale.  
 
3.5.1 Limitations  
There are several limitations to this pilot study. First, its cross-sectional design does not allow for 
the firm establishment of temporality between allostatic load and semen quality. Because allostatic load is 
a construct designed to capture cumulative stress over the life course and contains measures that reflect 
long-term biological processes, however, it theoretically should reflect embodied stress prior to the period 
of spermatogenesis. Second, because of the infeasibility of collecting first morning urine or a 12-hour 
urine sample in this pilot study, norepinephrine, epinephrine, and cortisol were not included in the 
allostatic load scale (a random urine sample would not yield reliable measures of these hormones, which 
vary diurnally(233)). Third, because subjects were recruited when they arrived at the clinic, they were not 




total and HDL cholesterol measures according to a large Canadian study(234). Fourth, because of 
restrictions on nursing staff availability, only a single blood pressure measure was taken. Because initial 
blood pressure readings are generally elevated, especially in clinical settings(235), it is possible that there 
could have been nondifferential misclassification of systolic and diastolic blood pressure measurements, 
but any resulting bias would be small and toward the null. Subjects were also weighed rather than having 
their waists and hips measured, therefore BMI was used as a component of the allostatic load score 
rather than waist-hip ratio, the preferred anthropometric measure of central adiposity. Fifth, although it is 
considered optimal for two semen samples to be obtained and the results averaged, CWRC subjects only 
provided a single sample. Studies conducted in both Norway and China have concluded that for 
epidemiologic research, as contrasted to clinical diagnosis, a single sample is a sufficiently accurate 
indicator of semen quality(236, 237). Sixth, the small sample size reduced the likelihood of finding 
statistically significant results and prohibited factor analyses of the allostatic load scale. Factor analysis 
would have been useful in determining whether the division into metabolic and nonmetabolic subdomains 
best reflected the underlying structure of the data. Performing multiple comparisons in such a small 
cohort is unfortunately unavoidable; this study was intended to provide impetus for a larger study in the 
future. Finally, as is common in semen quality research, the generalizability of the results is restricted 
because participants were recruited from a fertility clinic. 
An additional limitation that applies not only to this study but to all studies of allostatic load is the 
inability to fully distinguish the biological effects of cumulative stress from current stress. Several of the 
measures commonly included in allostatic load, such as systolic and diastolic blood pressure and HbA1c, 
can vary substantially in response to current or recent conditions, and transient high levels can increase 
allostatic load scores. In the case of a health outcome that takes years or decades to develop, it may still 
be convincingly argued that an association with allostatic load may be attributable to cumulative stress. In 
the case of a health outcome such as spermatogenesis, which takes place within a relatively short time 






 The main strengths of this study are the high-quality exposure and outcome measures. Blood 
samples were all taken at the same time of day and were analyzed at an NIH-funded CTSA research 
laboratory. The seven biomarker assays have excellent inter- and intra-assay precision measures 
(Supplemental Table 3.2), and all of the blood samples were run simultaneously, averting any batch 
effect. The semen was collected and processed according to a validated protocol by experienced clinical 
and laboratory personnel. 
 
3.5.3 Conclusion 
 Allostatic load was not associated with sperm concentration or percent normal morphology in our 
diverse sample of men from an urban fertility clinic. Those with ≥1 allostatic load indicators had on 
average 17.71 (95% CI [6.03, 29.38]) points higher percent progressive motility than those with no 
allostatic load indicators, adjusting for covariates. This relationship appeared to be driven by the 6 
subjects in the lowest allostatic load category who differed from the rest on mean testosterone level and 
possibly other unmeasured variables. The metabolic subdomain of allostatic load was significantly 
positively correlated with both sperm concentration and motility in adjusted analysis, and there was a 
negative but not statistically significant correlation with concentration. This pilot study suggests that the 
relationship between cumulative stress, operationalized as allostatic load, and semen quality may differ 
from that of recent stress, and that metabolic function may be linked to sperm concentration and motility. 
It also highlights the caveat that using a total allostatic load score to measure the impact of cumulative 
stress on a health outcome may mask associations with particular subdomains or even individual 
biomarkers that can provide information useful for identifying biological mechanisms. Future studies of 
allostatic load and semen quality that collect additional markers of HPA axis and sympathetic nervous 





Table 3.1. Characteristics of the Center for Women’s Reproductive Care sample (n=61). 
 
  mean (SD) median (range) 
Age 38.9 (5.9) 37.8 (27-53) 
BMI (continuous) 28.2 (5.1) 26.5 (20.1-44.3) 
Concentration (10⁶ /mL) 47.4 (29.0) 43.7 (0.2-132.1) 
% Progressive motility 41.2 (14.3) 40 (8-69) 
% Normal morphology 2.3 (1.7) 2 (0-6) 
Testosterone (ng/dL) 404.8 (151.7) 358 (111-843) 
  n (percent)   
US birth     
Yes 36 (59.0)   
No 25 (41.0)   
Race     
White 37 (60.7)   
Black 4 (6.6)   
Hispanic 15 (24.6)   
Other  5 (8.2)   
Education     
<Bachelors degree 17 (27.9)   
Bachelors degree 19 (31.2)   
>Bachelors degree 25 (41.0)   
Income     
<$100,000 22 (36.7)   
$100-150,000 11 (18.3)   
>$150,000 27 (45.0)   
BMI     
<25 17 (27.9)   
≥25 to <30 26 (42.6)   
≥30 to <35 10 (16.4)   
≥35 8 (13.1)   
Current smoking     
Yes 4 (6.6)   
No 57 (93.4)   
Exercise     
None 6 (10.0)   
>0 to <4 hours/week 17 (28.3)   
4 to 8 hours/week 20 (33.3)   
>8 hours/week 17 (28.3)   
Job strain     
Low 43 (78.2)   
High 12 (21.8)   
Alcohol     
None 8 (13.1)   






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.1. Adjusted boxplots of mean semen parameters for each allostatic load level. 






†	Allostatic load (AL)=0, n=6; AL=1, n=10; AL=2, n=18; AL=3, n=12; AL=4, n=5; AL=5, n=5; 
AL=6-7, n=5 
* combined because only 1 subject in level 7  
	 119 






† Allostatic load (AL)=0, n=12; AL=1, n=19; AL=2, n=15; AL=3, n=5; AL=4-5, n=10 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Table 3.4. Spearman correlations among semen parameters (n=61). 
 
Semen 
outcome 1 2 3 
1 Sperm concentration     
correlation 1     
p-value       
2 % Progressive 
motility     
correlation 0.33 1   
p-value 0.01     
3 % Normal morphology   
correlation 0.27 0.41 1 












Supplemental Table 3.5. Associations between allostatic load (AL) and measures of recent 
stress and depression. 
 




PSS 61 -0.04 0.77 








no adverse events 45 2.80 (1.85) 
 any adverse events 15 2.07 (1.16) 
 Job strain 
  
0.97 
low 43 2.60 (1.79) 
 high 12 2.58 (1.38) 
  
PSS: Perceived Stress Scale; CES-D: Center for Epidemiologic Studies Depression Scale; LEI: 





Supplemental Table 3.6. Characteristics of subjects with AL=0 vs. others. 
 
  AL=0 (n=6) AL>0 (n=55)   
  mean (SD) mean (SD) p-value 
Age 37.7 (5.6) 39.0 (6.0) 0.61 
BMI (continuous) 25.8 (2.5) 28.5 (5.2) 0.22 
Concentration 
(10⁶ /mL) 41.2 (29.7) 48.1 (29.2) 0.59 
% Progressive motility 26.8 (12.0) 42.8 (13.8) 0.01 
% Normal morphology 1.5 (1.4) 2.4 (1.7) 0.25 
Testosterone (ng/dL) 523.3 (192.6) 391.8 (142.8) 0.04 
FSH (mIU/mL) 4.0 (2.2) 4.6 (2.5) 0.56 
  n (percent) n (percent) p-value 
US birth     0.69 
Yes 4 (66.7) 32 (58.2)   
No 2 (33.3) 23 (41.8)   
Race     0.75 
White 4 (66.7) 33 (60.0)   
Black 0 (0) 4 (7.3)   
Hispanic 2 (33.3) 13 (23.6)   
Other  0 (0) 5 (9.1)   
Education     0.72 
<Bachelors degree 2 (33.3) 15 (27.3)   
Bachelors degree 1 (16.7) 18 (32.7)   
>Bachelors degree 3 (50.0) 22 (40.0)   
Income     0.45 
<$100,000 3 (50.0) 19 (35.2)   
$100-150,000 0 (0) 11 (20.4)   
>$150,000 3 (50.0) 24 (44.4)   
BMI     0.79 
<25 2 (33.3) 15 (27.3)   
≥25 to <30 3 (50.0) 23 (41.8)   
≥30 to <35 1 (16.7) 9 (16.4)   
≥35 0 (0) 8 (14.6)   
Current smoking     0.49 
Yes 0 (0) 4 (7.3)   
No 6 (100) 51 (92.7)   
Exercise     0.16 
None 0 (0) 6 (11.1)   
>0 to <4 hours/week 3 (50.0) 14 (25.9)   
4 to 8 hours/week 0 (0) 20 (37.0)   
>8 hours/week 3 (50.0) 14 (25.9)   
Job strain     0.22 
Low 5 (100) 38 (76.0)   
High 0 (0) 12 (24.0)   
Alcohol     0.12 
None 2 (33.3) 6 (10.9)   
Any 4 (66.7) 49 (89.1)   
 
AL: allostatic load score; BMI: body mass index  
	 129 
Supplemental Figure 3.1. Hypothesized causal diagram of the relationship between 






* Although allostatic load theoretically represents cumulative stress over the life course, some of 
its components may be influenced by current stress, hence the dotted line  
	 130 
Supplemental Figure 3.2. Histograms of semen outcomes measures. 
 
A. Sperm concentration 
 
 
B. Percent progressive motility 
 
 
C. Percent normal morphology 
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Supplemental Figure 3.3. Percentages of subjects in each allostatic load category below 
World Health Organization reference levels for concentration, motility, and morphology. 







†	Allostatic load (AL)=0, n=6; AL=1, n=10; AL=2, n=18; AL=3, n=12; AL=4, n=5; AL=5, n=5; 




































Normal morphology <4% 
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† Allostatic load (AL)=0, n=12; AL=1, n=19; AL=2, n=15; AL=3, n=5; AL=4&5 (combined because 








































Normal morphology <4% 
	 133 
Supplemental Figure 3.4. Percentage of subjects meeting 0, 1, 2, or 3 World Health 




















Because semen quality is not only a measure of male fertility but also a potential indicator 
of male health, it is important to understand predictors of poor semen quality and attempt to 
identify modifications in behavior and environment that may improve it. The results of my 
dissertation research impart as much about the relationship of adiposity and stress to semen 
quality as they do about considerations for future research in this area. Following are some 
caveats and recommendations. 
 
Check for nonlinear associations. 
 The main finding of my systematic review was similar to that of Sermondade et al.’s 
meta-analysis(39). While they reported a J-shaped relationship in which under- and 
overweight/obese men were more likely to be azoospermatic or oligospermatic (to have no or low 
sperm count) compared to normal weight men, we concluded that the relationship between body 
mass index (BMI) and sperm concentration was likely to have an inverse U-shape. Most of the 
studies I examined found no association between BMI and sperm concentration, and the ones 
that found a negative association were more often conducted among populations with higher 
proportions of overweight and obese men. Studies that included only young men, which tended to 
have lower mean BMI, showed no associations and the single study that reported a positive 
association was conducted among a mixed-age group of men with a low mean BMI. It is therefore 
important not only to test for nonlinear relationships between BMI and semen outcomes, but to 
insure that there is adequate distribution of BMI within the sample population to detect 
nonlinearity at the high and low ends of the curve.  
 
Cross-sectional studies may not tell the whole story. 
Although it is convenient—especially in semen quality studies—to collect cross-sectional 
data or mine the records of fertility clinics and andrology labs for results that can be linked to 
subjects’ demographic information, a true understanding of how risk factors affect sperm 
concentration, motility, and morphology—as well as other parameters that were not covered in 
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my studies, such as DNA fragmentation—requires a longitudinal design. While the division, 
proliferation, and maturation of sperm stem cells into spermatozoa occurs in less than 3 months, 
factors that affect the quantity and quality of those stem cells, including the number and functional 
health of the Sertoli and Leydig cells in the testes, may date back to the prenatal period.  
A key example of what is missed in cross-sectional studies is my finding relating to BMI 
and sperm concentration in the Study of the Environment and Reproduction. When linked to data 
from Child Health and Development Studies, the combined longitudinal data set spanned more 
than 4 decades and included information from various developmental stages. If I had only 
analyzed the data cross-sectionally, I would have concluded that there was no association 
between adiposity and semen quality. Because I had access to birth weight and childhood 
adiposity measures, however, I was able to tell a different story that revealed potentially important 
information about the effects of the intrauterine environment and of early childhood overweight 
and obesity. Specifically, higher birth weight for gestational age is associated with increased 
sperm concentration, likely because more Sertoli cells, which give rise to sperm stem cells, are 
laid down in the testes of fetuses that have the opportunity to maximize their growth 
potential(161). Postnatally, however, the direction of the association changes. This suggests that 
early life adiposity may interfere with the development of testosterone-producing Leydig cells, 
which undergo crucial transformations in early childhood, and thereby impede sperm production 
in adulthood. 
Similarly, had I only looked at the association between BMI at the time of semen 
collection and sperm motility, I would have concluded that there was no association. But having 
adiposity measures at two time points earlier in adulthood allowed me to see a negative 
association between obesity in subjects’ 20s and motility at mean age 43 (among those 
overweight at 4 years, the relationship was already apparent). The association was attenuated at 
later ages, suggesting that it resulted from an accumulation of damage among those who had 
high BMI for the longest period of time, an interpretation borne out in the cumulative analysis. 
 
Pay attention to puberty. 
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The years leading up to puberty and throughout adolescence are potentially critical 
periods in which adiposity or other exposures might negatively affect future semen quality 
because both Sertoli and Leydig cells undergo proliferation and maturation during this time(158, 
162). Unfortunately, my data set lacked information adiposity measures between age 4 and 
subjects’ 20s, so I was unable to investigate associations within this important developmental 
window. In addition to collecting data at regular intervals so as to avoid having such a frustrating 
gap, future longitudinal studies should collect information on sexual development, such as Tanner 
stages and date of first ejaculation. Having a marker of sexual maturity would permit an analysis 
to be structured according to biological rather than chronological age (e.g., time pre- or post-first 
ejaculation), which may be more relevant in the context of semen quality research(238).  
 
Collect serial semen samples. 
In addition to collecting prenatal data (including paternal semen samples), as well as 
anthropometric measures, biological samples, behavioral data, and assessments of physical and 
sexual development at regular intervals, the ideal longitudinal semen quality study would include 
serial semen samples collected from adolescence through adulthood. Having repeated measures 
of both exposures and outcomes would allow subjects to serve as their own controls and permit 
the study of changes in BMI or other exposures (e.g., exercise, diet, sleep) on semen quality. 
This method was used in some of the studies I reviewed that assessed the relationship between 
stress due to infertility treatment and semen quality(180, 187, 188, 193, 201). In the BMI 
literature, it has only been used to assess the effect of weight loss on semen quality among 
severely obese men through either a structured weight-loss program(77) or bariatric surgery(239-
243). Large studies of this nature could provide valuable information about whether or not a 
change in a particular exposure is associated with a change in semen quality. Repeated semen 
quality measures could also provide an alternative means of assessing critical period effects. The 
method I used—adding sequential adiposity measures into the same model--was severely limited 
by the collinearity of the predictors. With repeated exposure and outcome measures, it would be 
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possible to assess whether or not there is a critical period in the life course when a change in 
exposure might have a lasting beneficial or deleterious effect on semen quality. 
 
Think beyond the World Health Organization (WHO). 
Studies of semen quality—especially those that rely on data collected at fertility clinics or 
andrology labs—generally restrict themselves to the conventional semen parameters for which 
the WHO has published lower reference limits and which are therefore usually assessed as part 
of a routine fertility work-up. In addition to concentration, motility and morphology, these include 
volume, total sperm count, and vitality(147). Recent studies have indicated that other 
characteristics, including sperm DNA fragmentation (reviewed in (244, 245)), sperm epigenetics 
(reviewed in (246, 247)), sperm telomere length(248-251), reactive oxygen species produced by 
sperm(252, 253), and presence of inflammatory cytokines in seminal fluid(254, 255) may also be 
relevant outcomes for semen quality research. In all cases, efforts should be made to measure 
biomarkers in the seminal fluid, as concentrations may differ between blood and semen(224, 226, 
227). 
 
Seek a biological explanation. 
 Studies that report negative associations between psychosocial stress or life event stress 
and semen quality have played an important role in confirming the observed phenomenon of 
reduced fertility in times of poverty, war, and famine(256-259). However they do not provide any 
information on which biological systems are compromised by stress and how those systems 
might be linked to the regulation of semen quality. Without this information, the only public health 
message to result from these studies is to “avoid stress.” If, as Last writes, the definition of 
epidemiology includes the application of the results of our research “to the control of health 
problems”(260), it is essential that we design studies that yield more specific, practical 
information.  
I designed my pilot study of allostatic load, theoretically a construct that represents 
cumulative stress, and semen quality with the aim of discovering which biological mechanisms 
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were most responsible for observed associations of stress with sperm concentration, motility, and 
morphology. Because allostatic load comprises biomarkers and physical measures that represent 
various regulatory systems in the body, it is a useful tool for probing possible biological pathways. 
(Whether it indeed represents a distinct construct from recent stress is debatable; in my study, 
the allostatic load components that were most strongly correlated with the semen outcomes 
tended to be those that fluctuated in response to proximal events, such as blood pressure, 
glycosylated hemoglobin, and serum albumin.) Although my study had multiple drawbacks, the 
findings illustrate this point. The full allostatic load scale was positively associated with motility, 
but when the allostatic load scale was split into its metabolic and non-metabolic subdomains, it 
became apparent that the positive association was driven by the metabolic subdomain. Within 
that subdomain, BMI had the strongest positive signal. In the case of sperm concentration, I 
found no association with the full allostatic load scale, but a significant positive association with 
the metabolic subdomain and a nonsignificant negative association with the non-metabolic 
subdomain. In this case, BMI contributed relatively little to the positive association; systolic blood 
pressure and glycosylated hemoglobin predominated. Were these results from a larger study with 
fewer limitations, they might lead to further research into how these particular symptoms connect 
to the dysregulation of sperm production that could eventually result in clinical recommendations.  
 
The results of my studies of adiposity and stress as potentially modifiable risk factors for 
semen quality have reinforced my belief in the importance of a biologically-based life course 
approach to epidemiologic research. We can only hope to unravel some of the complexities of the 
interactions between not only age, period, and cohort, but also environment, behavior, heredity, 
and—most importantly—human biology if we have data that covers the entire life span. In the 
case of reproductive heath, where the cells that give rise to gametes are present from the 
prenatal period, and those gametes can transmit epigenetic changes to offspring, 
intergenerational effects also come into play, necessitating the establishment of multigenerational 
cohorts. This dissertation project has both enlightened me to the challenges inherent in the field 
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of reproductive epidemiology and inspired me to try to meet some of those challenges in my 
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